Experiments for taxon Tripterygium wilfordii (CELASTRACEAE)

Experiments (1863 results)

Filters
Worktypes (50)
400
371
282
275
233
228
214
202
195
192
186
169
141
106
101
77
56
56
46
26
22
20
18
17
17
13
11
9
7
7
5
5
4
3
3
3
3
3
3
3
3
2
2
2
2
2
1
1
1
1
No match
Pharmacology (159)
197
139
95
62
52
39
36
35
32
30
28
28
27
26
24
21
19
19
19
15
13
13
12
11
8
8
8
8
8
7
7
6
5
5
5
5
5
5
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
589
No match
Compounds (301)
96
65
41
23
21
20
19
19
19
18
18
17
17
15
14
13
13
13
13
13
11
10
10
10
9
8
8
8
8
8
8
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
6
6
6
6
6
6
6
6
5
5
5
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
688
No match
44 rarer values not listed
Organisms (300)
105
102
76
62
51
47
39
35
30
25
18
18
18
18
17
15
14
14
13
12
12
11
11
10
10
10
10
10
9
9
9
9
9
9
8
8
8
8
8
8
8
8
8
8
8
7
7
7
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
No match
211 rarer values not listed
1863 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)Compound
284588
PHARMACOLOGY OF COMPOUND - IN VITRO
TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORIC ACID A
630728
PHARMACOLOGY OF EXTRACT - IN VITRO
CELL ADHESION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
521634
ISOLATION AND IDENTIFICATION OF
CELL PROLIFERATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDE
911997
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFORMINE
596419
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
729578
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
DITERPENE TW-19
638323
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
COMPOUND TZ-93
251620
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
WILFORIC ACID D
761904
PHARMACOLOGY OF EXTRACT - IN VITRO
NITRIC OXIDE SYNTHASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
248402
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERIFORDIN
970485
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDE
1227022
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
970488
PHARMACOLOGY OF EXTRACT - IN VITRO
LYMPHOCYTE SUPPRESSION
Tripterygium wilfordii (CELASTRACEAE)
269349
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERFERON-GAMMA SECRETION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORDININE J
269361
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-2 FORMATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE G
58881
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTINEPHRITIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
59447
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFORDINE
248404
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION AND IDENTIFICATION OF
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERIFORDIN
694466
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
489831
PHARMACOLOGY OF EXTRACT - IN VIVO
PERCUTANEOUS ABSORPTION ENHANCEMENT
Tripterygium wilfordii (CELASTRACEAE)
138501
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
SITOSTEROL,BETA:
269322
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE D
1269946
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
INSECTICIDE ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1282350
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPFORDINE A
1216702
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1231005
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
961222
PHARMACOLOGY OF EXTRACT - IN VIVO
TOXIC EFFECT(GENERAL)
Tripterygium wilfordii (CELASTRACEAE)
208454
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTININ B
534173
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TW-22
1187247
ANTIFERTILITYPHARMACOLOGY OF EXTRACT - IN HUMANS
SPERMICIDAL EFFECT
Tripterygium wilfordii (CELASTRACEAE)
251613
PHARMACOLOGY OF COMPOUND - IN VITRO
TUMOR NECROSING FACTOR INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
DULCIOIC ACID
480371
PHARMACOLOGY OF EXTRACT - IN VITRO
MISCELLANEOUS EFFECTS
Tripterygium wilfordii (CELASTRACEAE)
620938
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
425714
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
129841
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE,16-HYDROXY:
560914
PHARMACOLOGY OF COMPOUND - IN VITRO
SPASMOLYTIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
WILFORLIDE A
521628
PHARMACOLOGY OF EXTRACT - IN VITRO
CELL PROLIFERATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
961221
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
248415
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION AND IDENTIFICATION OF
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
MANOYL OXIDE-18-OIC ACID,13-EPI:
534198
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TW-32
269404
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-4 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONINE A#
1227526
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE,17-HYDROXY:
560943
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
CANGORONIN
178377
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
EUONYMINE
534208
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TW-42
958399
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
685901
PHARMACOLOGY OF EXTRACT - IN VITRO
MISCELLANEOUS EFFECTS
Tripterygium wilfordii (CELASTRACEAE)
284568
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN 8 SYNTHESIS INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
850876
PLANT TISSUE CULTURE MARKER CODEIDENTIFICATION IN BY TLCWORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATA REPORTED
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDE
269321
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERFERON-GAMMA SECRETION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE C
856923
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
CELASTROL
208447
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
REGELIN
534187
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TW-27
1282349
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPFORDINE A
267585
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOTIN J
12175
X-RAY CHRYSTALLOGRAPHIC STUDIESSTRUCTURE DETERMINATION OFANTICANCER AND/OR CYTOTOXICITY MARKER CODE
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDETRIPTOLIDE
269400
PHARMACOLOGY OF COMPOUND - IN VITRO
TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONINE A#
248413
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION AND IDENTIFICATION OF
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
MANOYL OXIDE-18-OIC ACID,13-EPI:
480373
PHARMACOLOGY OF EXTRACT - IN VITRO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
426729
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
INSECTICIDE ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
269336
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
WILFORDININE I
1269897
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
INSECTICIDE ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
389094
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
SPERMICIDAL EFFECT
Tripterygium wilfordii (CELASTRACEAE)
523001
REVIEW OF
Tripterygium wilfordii (CELASTRACEAE)
831573
PLANT TISSUE CULTURE MARKER CODEQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDE
421268
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
284574
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN 8 SYNTHESIS INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
TRIPTODIOLIDE
352095
PHARMACOLOGY OF EXTRACT - IN VITRO
INTERFERON-GAMMA SECRETION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
607293
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
TRIPCHLOROLIDE
1223468
IDENTIFICATION IN BY TLCQUANTITATIVE DATA REPORTED
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
355767
PHARMACOLOGY OF EXTRACT - IN VITRO
INTERLEUKIN-4 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
694261
PHARMACOLOGY OF EXTRACT - IN VITRO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
69167
CLINICAL STUDIES
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
534192
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TW-28
303108
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOWILFOLIDE
596433
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOPHENOLIDE,ISO:
1299614
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1269867
UV SPECTRUM GIVEN FORISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
WILFORZINE
490525
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1227435
PLANT TISSUE CULTURE MARKER CODEIDENTIFICATION IN BY TLC
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDETRIPTOLIDE
355773
PHARMACOLOGY OF EXTRACT - IN VITRO
IMMUNOGLOBULIN PRODUCTION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
352895
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
963015
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
537849
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
HYPOLIDE METHYL ETHERTRIPTOPHENOLIDE,ISO-NEO:TRIPTONOLIDE
95083
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONOLIDE,NEO:
560932
PHARMACOLOGY OF COMPOUND - IN VITRO
SPASMOLYTIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
WILFOROL D
171428
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE
1216761
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2
1280134
REVIEW OF
Tripterygium wilfordii (CELASTRACEAE)
1280094
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
AGAROFURAN,DIHYDRO: 1-BETA-2-BETA-3-ALPHA-5-ALPHA-7-BETA-8-BETA-11-HEPTAACETOXY:
1216721
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-3
207658
PMR SPECTRUM REPORTEDPLANT TISSUE CULTURE MARKER CODECMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
IFFLAIONIC ACID
284510
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
URS-12-EN-30-OIC ACID,22-BETA-HYDROXY-3-OXO:
158227
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE,16-HYDROXY:
427180
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIMULTIPLE SCLEROSIS EFFECT
Tripterygium wilfordii (CELASTRACEAE)
284552
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
KAURANE-17-19-DIOIC ACID
138489
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-EN-29-OIC ACID,3-BETA-22-BETA-DIHYDROXY:
685906
PHARMACOLOGY OF EXTRACT - IN VITRO
IMMUNOLOGIC EFFECTS(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
534165
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
TW-19
269327
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-4 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE D
958408
TOXICITY MARKER CODEPHARMACOLOGY OF EXTRACT - IN HUMANS
NEPHROTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1269904
PHARMACOLOGY OF EXTRACT - IN VITRO
FEEDING DETERRENT(INSECT)
Tripterygium wilfordii (CELASTRACEAE)
1269934
PHARMACOLOGY OF EXTRACT - IN HUMANS
TOXIC EFFECT(GENERAL)
Tripterygium wilfordii (CELASTRACEAE)
1226675
PHARMACOLOGY OF EXTRACT - IN VIVO
TOXIC EFFECT(GENERAL)
Tripterygium wilfordii (CELASTRACEAE)
14570
PHARMACOLOGY OF EXTRACT - IN VIVOPMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONIDE
152440
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE,13-14-EPOXY-9-11-12-TRIHYDROXY:
515050
HPLC DATA REPORTEDIDENTIFICATION IN BY HPLCQUANTITATIVE DATA
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDE
355768
PHARMACOLOGY OF EXTRACT - IN VITRO
PROSTAGLANDIN SYNTHESIS INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
960695
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTINEPHRITIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
490540
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTINEPHRITIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
970494
PHARMACOLOGY OF EXTRACT - IN VITRO
LYMPHOCYTE(B) SUPPRESSION
Tripterygium wilfordii (CELASTRACEAE)
647250
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1226614
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
TRIPCHLOROLIDE
534162
PHARMACOLOGY OF COMPOUND - IN VITROANTIFERTILITY
SPERMICIDAL EFFECT
Tripterygium wilfordii (CELASTRACEAE)
TW-19
675982
PHARMACOLOGY OF EXTRACT - IN VIVO
NITRIC OXIDE SYNTHESIS INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
560917
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFOROL A
952491
PHARMACOLOGY OF EXTRACT - IN VITRO
LYMPHOCYTE(B) STIMULATION
Tripterygium wilfordii (CELASTRACEAE)
284493
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN 8 SYNTHESIS INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
KAURANE,16-ALPHA-HYDROXY-19-20-EPOXY-19(R)-ETHOXY:
1216770
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-3
490520
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIPSORIATIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1231016
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPCHLOROLIDE
1216707
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-1
1223489
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFORZINEWILFORTRINEWILFORGINEWILFORDINEWILFORINE
284584
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERFERON-GAMMA SECRETION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOCHLOROLIDE
426730
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
INSECTICIDE ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
534184
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TW-27
1231009
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDE
560935
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-EN-28-OIC ACID,3-ALPHA-24-DIHYDROXY:
1216781
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
SPERMICIDAL EFFECT
Tripterygium wilfordii (CELASTRACEAE)
TRIPCHLOROLIDE
356866
PHARMACOLOGY OF COMPOUND - IN VITRO
CELL PROLIFERATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
ZEYLASTERAL,DEMETHYL:
178161
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONOTERPENOL
426710
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTINEPHRITIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
368689
PHARMACOLOGY OF EXTRACT - IN VITRO
CYCLOOXYGENASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
1223478
X-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOTRITERPENIC ACID B
284563
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-2 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOBENZENE J
1216746
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-6
284521
PHARMACOLOGY OF COMPOUND - IN VITRO
TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-ENE-22-29-LACTONE,2-ALPHA-3-BETA-DIHYDROXY:
647254
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
ALLOGRAFT REJECTION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
1226593
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2
960686
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1000679
PHARMACOLOGY OF EXTRACT - IN VITROPLANT TISSUE CULTURE MARKER CODEIDENTIFICATION IN BY TLCANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDETRIPTOLIDE
352901
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1216713
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-2
626539
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
ALLOGRAFT REJECTION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
356863
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
ZEYLASTERAL,DEMETHYL:
421265
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
560910
PHARMACOLOGY OF COMPOUND - IN VITRO
SPASMOLYTIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
ABIETA-8-11-TRIEN-3-ONE,14-HYDROXY:
1216718
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
SPERMICIDAL EFFECT
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-2
593178
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTINEPHRITIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
1223487
PHARMACOLOGY OF COMPOUND - IN VITRO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPCHLOROLIDE
952485
PHARMACOLOGY OF EXTRACT - IN VITRO
T-LYMPHOCYTE SUPPRESSION
Tripterygium wilfordii (CELASTRACEAE)
560924
PHARMACOLOGY OF COMPOUND - IN VITRO
SPASMOLYTIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
ZEYRASTERAL,DEMETHYL
1216706
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-1
960675
PHARMACOLOGY OF EXTRACT - IN HUMANS
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1226607
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPCHLOROLIDE
421264
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
176719
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
WILFOROL D
280056
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOTIN FTRIPTOTIN G
514713
PHARMACOLOGY OF EXTRACT - IN VITROTOXICITY MARKER CODEANTIFERTILITY
EMBRYOTOXIC EFFECT(RELATED TO FERTILITY REGULATION)
Tripterygium wilfordii (CELASTRACEAE)
907851
PHARMACOLOGY OF EXTRACT - IN VIVO
TOXICITY ASSESSMENT(QUANTITATIVE)
Tripterygium wilfordii (CELASTRACEAE)
523005
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
248390
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION AND IDENTIFICATION OF
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOQUINONE C
1226588
PHARMACOLOGY OF EXTRACT - IN VITRO
INTERLEUKIN-2 FORMATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
596420
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
107910
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
WILFORINE,2-DEBENZOYL: 2-NICOTINOYL:
1227037
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
1223476
PHARMACOLOGY OF COMPOUND - IN VIVO
TOXICITY ASSESSMENT(QUANTITATIVE)
Tripterygium wilfordii (CELASTRACEAE)
WILFORTRINE
958079
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIMITOTIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
534203
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TW-36
408112
X-RAY CHRYSTALLOGRAPHIC STUDIESPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONIDE
907030
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
429019
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
616163
VOUCHER SPECIMEN REPORTED FORYIELD IS MORE THAN 100 MGMQUANTITATIVE DATAPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
419127
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTILUPUS ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
208443
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
WILFORIC ACID C
284557
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-4 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
KAURANE-17-19-DIOIC ACID
269338
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-1-BETA RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORDININE I
1226770
PHARMACOLOGY OF COMPOUND - IN VIVO
TOXICITY ASSESSMENT(QUANTITATIVE)
Tripterygium wilfordii (CELASTRACEAE)
HYPOLIDE
69827
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
WILFORLIDE AWILFORLIDE B
519896
PRESENT IN (REVIEW)
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDE
952493
PHARMACOLOGY OF EXTRACT - IN VITRO
INTERLEUKIN-1 FORMATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
596415
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
255666
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFORONIDE
1269909
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
INSECTICIDE ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1020184
PLANT TISSUE CULTURE MARKER CODEQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
1227095
REVIEW OF
Tripterygium wilfordii (CELASTRACEAE)
381250
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
667378
PHARMACOLOGY OF EXTRACT - IN VITRO
COLONY FORMATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
560903
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOQUINONE B
352899
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1227528
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE,17-HYDROXY:
960226
PHARMACOLOGY OF EXTRACT - IN VITRO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
971154
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
INSECTICIDE ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
161531
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTRIOLIDE,12-EPI:
269399
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONINE A#
914637
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONOLIDE
251644
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-4 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
KATONIC ACID,3-EPI:
429020
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIBODY FORMATION SUPPRESSION
Tripterygium wilfordii (CELASTRACEAE)
207664
PLANT TISSUE CULTURE MARKER CODEQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TINGENONE
138499
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-EN-29-OIC ACID,22-BETA-HYDROXY-3-OXO:
421257
TOXICITY MARKER CODEPHARMACOLOGY OF EXTRACT - IN HUMANS
TOXIC EFFECT(GENERAL)
Tripterygium wilfordii (CELASTRACEAE)
258050
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFORLIDE A
492500
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
269317
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-1-BETA RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE C
960668
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
ANTIPSORIATIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
490539
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
284543
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
FRIEDOOLEAN-29-OIC ACID,24-NOR-D: A: 2-3-DIHYDROXY-1-3-5(10)-7-TETRAENE-6-BETA(1'-HYDROXY-ETHYL):
1216728
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-4
284495
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-2 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
KAURANE,16-ALPHA-HYDROXY-19-20-EPOXY-19(R)-ETHOXY:
286570
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
WILFORDCONINE
1223483
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOTRITERPENIC ACID A
269347
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-2 FORMATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORDININE J
1226582
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIMITOGENIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1148115
IDENTIFICATION OFQUANTITATIVE DATA REPORTED
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
911975
PMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDE
284559
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
KAURANE-16-19-20-TRIOL
521631
PHARMACOLOGY OF EXTRACT - IN VITRO
INTERLEUKIN-2 FORMATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
1017380
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
1226625
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-28
251631
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
FRIEDELAN-29-ALPHA-CARBOXYLIC ACID,3-BETA-HYDROXY-2-OXO:
699023
PHARMACOLOGY OF EXTRACT - IN VITRO
CELL PROLIFERATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
248371
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOBENZENE M
560906
PHARMACOLOGY OF COMPOUND - IN VITRO
SPASMOLYTIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOQUINONE C
176505
CMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFORTRINE
258053
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
FRIEDEL-3-EN-20-ALPHA-CARBOXYLIC ACID,3-HYDROXY-2-OXO:CANGORONINE
138504
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
ABIETA-3-8-11-13-TETRAEN-3-OIC ACID,18-NOR: 15-HYDROXY:
914634
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIMITOGENIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
1218974
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
963012
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
TOXIC EFFECT(GENERAL)
Tripterygium wilfordii (CELASTRACEAE)
1216765
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2
534176
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TW-23
381249
PHARMACOLOGY OF EXTRACT - IN VIVO
TUMOR NECROSING FACTOR SECRETION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
248410
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION AND IDENTIFICATION OF
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
MANOYL OXIDE-18-OIC ACID,13-EPI:
395405
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
ZEYLESTERAL,DEMETHYL:
386079
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFORDINE
534195
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TW-31
1280098
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
AGAROFURAN,DIHYDRO: 1-BETA-2-BETA-5-ALPHA-TRIACETOXY-4-ALPHA-HYDROXY-7-BETA-11-DIISO-BUTYRYL-OXY-8-ALPHA-FURANOYL:
910836
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
HYPOLIDE METHYL ETHER
495645
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
SPERMICIDAL EFFECT
Tripterygium wilfordii (CELASTRACEAE)
560946
PHARMACOLOGY OF COMPOUND - IN VITRO
SPASMOLYTIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
FRIEDOOLEAN-3-EN-2-ON-29-OIC ACID,D: A: 3-HYDROXY:
200742
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOQUINONE A
68909
REVIEW OF
Tripterygium wilfordii (CELASTRACEAE)
534141
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TW-1
248374
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOBENZENE M
1216754
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-8
960714
PHARMACOLOGY OF EXTRACT - IN VIVO
NEPHROTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1226969
PRESENT IN (REVIEW)REVIEW OF
Tripterygium wilfordii (CELASTRACEAE)
WILFORMINETRIPDIOLIDETRIPTONOTERPENE METHYL ETHERWILFORLIDE ASALASPERMIC ACIDWILFORIDINETRIPTOTRITERPENIC ACID BTRIPTONOTERPENOLWILFORZINEKATONIC ACID,3-EPI:WILFORINE,NEO:TRIPTOPHENOLIDE METHYL ETHERTRIPTOPHENOLIDE,NEO: ISO:WILFORTRINECELARUFINEWILFORGINETRIPTONOTERPENETRIPTODIHYDROXY ACID METHYL ESTERHYPOLIDEWILFORNINETRIPTONIDEWILFORDINETRIPTOPHENOLIDE,NEO:TRIPTOLIDENOLTRIPTOTRITERPENIC ACID AFRIEDELAN-29-OIC ACID,3-24-DIOXO:TRIPTOLIDECELABENZINETRIPTONOLIDECELACINNINETRIPTOTRITERPENIC ACID CWILFORINE
1227523
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE,15-HYDROXY:
68404
PHARMACOLOGY OF EXTRACT - IN HUMANS
INTERLEUKIN-2 FORMATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
958411
PHARMACOLOGY OF EXTRACT - IN VIVOTOXICITY MARKER CODE
TOXIC EFFECT(GENERAL)
Tripterygium wilfordii (CELASTRACEAE)
1216738
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-5
1216778
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPCHLOROLIDE
620940
PHARMACOLOGY OF EXTRACT - IN VIVO
TUMOR NECROSING FACTOR SECRETION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
269306
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-4 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE A
426723
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTINEPHRITIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
1226617
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPCHLOROLIDE
1282357
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFORJINE
910264
ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOPHENOLIDE,NEO:
1216703
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
397830
PHARMACOLOGY OF COMPOUND - IN VITRO
RADICAL SCAVENGING EFFECT
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
176712
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
WILFOROL A
352905
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
534180
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TW-25
626535
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
958403
X-RAY CHRYSTALLOGRAPHIC STUDIESISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOPHENOLIDE,NEO:
1228026
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTILH ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
429018
PHARMACOLOGY OF EXTRACT - IN VIVO
LYMPHOCYTE SUPPRESSION
Tripterygium wilfordii (CELASTRACEAE)
1216714
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-2
251599
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
WILFORIC ACID E
457655
PHYTOCHEMICAL SCREENING FORQUANTITATIVE DATA
Tripterygium wilfordii (CELASTRACEAE)
O
596426
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDE
958426
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
138496
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TINGENONE,22-BETA-HYDROXY:
176715
CMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
ZEYLASTEROL,DEMETHYL:
248394
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
KAURAN-19-OIC ACID,16-ALPHA: 17-HYDROXY: (-):
395404
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
ZEYLESTERAL,DEMETHYL:
1216786
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-6
1049937
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
WILFORLIDE A
1226584
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIMITOGENIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1226769
PHARMACOLOGY OF COMPOUND - IN VIVO
ASCORBIC ACID(ADRENAL)LOWERING EFFECT
Tripterygium wilfordii (CELASTRACEAE)
HYPOLIDE
952489
PHARMACOLOGY OF EXTRACT - IN VITRO
BENZODIAZEPINE BINDING INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
269358
PHARMACOLOGY OF COMPOUND - IN VITRO
TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE G
1223472
MASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFORINE
368694
PHARMACOLOGY OF EXTRACT - IN VITRO
CYCLOOXYGENASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
1269864
BIOSYNTHESISMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION FROM DURING BIOSYNTHESIS STUDY
Tripterygium wilfordii (CELASTRACEAE)
WILFORTRINEWILFORGINEWILFORDINEWILFORINE
596437
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOPHENOLIDE,ISO:
1216743
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-6
248383
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOBENZENE N
14571
X-RAY CHRYSTALLOGRAPHIC STUDIESMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDE
1226630
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-28
626531
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
LYMPHOCYTE SUPPRESSION
Tripterygium wilfordii (CELASTRACEAE)
251628
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOCALLIC ACID D
176982
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONOTERPENE,NEO: METHYL:
258054
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONIN C
970484
UV SPECTRUM GIVEN FORPLANT TISSUE CULTURE MARKER CODEISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDE
667741
PHARMACOLOGY OF EXTRACT - IN VIVO
NERVE REGENERATION
Tripterygium wilfordii (CELASTRACEAE)
533407
PHARMACOLOGY OF EXTRACT - IN VIVO
RENAL FUNCTION DECREASE
Tripterygium wilfordii (CELASTRACEAE)
803957
PHARMACOLOGY OF EXTRACT - IN VIVO
LUNG PROBLEMS(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
284532
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-EN-29-OIC ACID,3-BETA-28-DIHYDROXY:
1231010
PMR SPECTRUM REPORTEDISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
831575
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDE
914644
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
POLPUNONIC ACID
909525
PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
158224
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE,16-HYDROXY:
1227099
ANTIFERTILITYPHARMACOLOGY OF EXTRACT - IN HUMANS
LH-SYNTHESIS STIMULATION
Tripterygium wilfordii (CELASTRACEAE)
68405
PHARMACOLOGY OF EXTRACT - IN HUMANS
IMMUNOGLOBULIN PRODUCTION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
269388
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN 8 INDUCTION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
EUONYMINE
280621
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
NOBILETINMEDIORESINOL,(+):SYRINGARESINOL,(-):TRIPTERFORDIN
560921
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
CELASTROL
178166
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
WILFOROL F
914633
MASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
494933
DEPARTMENTAL MARKER CODE. NO DATA CODED
Tripterygium wilfordii (CELASTRACEAE)
1269875
UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
CELASTROL
1226611
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
TRIPCHLOROLIDE
1231013
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE,18-HYDROXY:
269366
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-1-BETA RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
EBENIFOLINE E-II
163360
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONOTERPENE METHYL ETHER
1223479
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOTRITERPENIC ACID B
284518
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-ENE-22-29-LACTONE,2-ALPHA-3-BETA-DIHYDROXY:
971159
BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Tripterygium wilfordii (CELASTRACEAE)
WILFORTRINEWILFORGINEWILFORDINEWILFORINE
284571
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-4 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
418525
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDENOL
654650
PHARMACOLOGY OF EXTRACT - IN VIVO
LYMPHOCYTE PROLIFERATION STIMULATION
Tripterygium wilfordii (CELASTRACEAE)
284499
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
KAURANE,16-ALPHA-HYDROXY-19-2-EPOXY-20(R)-ETHOXY:
284560
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-1-BETA-SYNTHESIS INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOBENZENE J
152438
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTRIOLIDE
960679
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1216873
MEDICINAL FOLKLORE REPORTED FOR
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1226595
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2
668767
PHARMACOLOGY OF EXTRACT - IN VITRO
SUPEROXIDE PRODUCTION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
1216792
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-8
148250
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTRIOLIDE,EPI:
596432
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOPHENOLIDE,ISO:
284590
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-4 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORIC ACID A
596429
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDE
269343
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
WILFORDININE J
248396
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION AND IDENTIFICATION OF
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
KAURAN-19-OIC ACID,16-ALPHA: 17-HYDROXY: (-):
534191
PHARMACOLOGY OF COMPOUND - IN VITROANTIFERTILITY
SPERMICIDAL EFFECT
Tripterygium wilfordii (CELASTRACEAE)
TW-28
674815
PHARMACOLOGY OF EXTRACT - IN VITRO
CELL ADHESION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
422997
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFORLIDE A
178160
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOQUINONE B
158221
UV SPECTRUM GIVEN FORX-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE,16-HYDROXY:
59444
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
INSECTICIDE ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
WILFORINE
248407
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION AND IDENTIFICATION OF
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERIFORDIN
534152
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TW-6
251640
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
KATONIC ACID,3-EPI:
958400
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
1227543
PHARMACOLOGY OF EXTRACT - IN VITRO
TESTOSTERONE LEVEL DECREASED
Tripterygium wilfordii (CELASTRACEAE)
171429
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE
691357
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1148107
PLANT TISSUE CULTURE MARKER CODEISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDE
181459
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE,16-HYDROXY:
258051
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
SALASPERMIC ACIDREGELINWILFORLIDE B
161526
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTRIOLIDE,12-EPI:
1235301
VOUCHER SPECIMEN REPORTED FORISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Tripterygium wilfordii (CELASTRACEAE)
CELAFURINECELABENZINE
284517
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
URS-12-EN-30-OIC ACID,28-HYDROXY-3-OXO:
418066
IDENTIFICATION IN BY TLCQUANTITATIVE DATA
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
248389
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION AND IDENTIFICATION OF
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOQUINONE C
626540
PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBED
METAPLASIA INDUCTION
Tripterygium wilfordii (CELASTRACEAE)
284529
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-2 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-EN-29-OIC ACID,28-HYDROXY-3-OXO:
251639
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
CANGORONINE
1216750
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-7
959878
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
560909
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
ABIETA-8-11-TRIEN-3-ONE,14-HYDROXY:
960708
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1282353
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPFORDINE C
651921
PHARMACOLOGY OF EXTRACT - IN VIVO
PLATELET-DERIVED GROWTH FACTOR B PRODUCTION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
248378
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOBENZENE N
534157
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TW-7
279041
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOCALLINE A,6-ALPHA-HYDROXY:
248414
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION AND IDENTIFICATION OF
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
MANOYL OXIDE-18-OIC ACID,13-EPI:
960687
PHARMACOLOGY OF EXTRACT - IN VIVO
TOXICITY ASSESSMENT(QUANTITATIVE)
Tripterygium wilfordii (CELASTRACEAE)
1223625
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
TOXIC EFFECT(GENERAL)
Tripterygium wilfordii (CELASTRACEAE)
914631
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONIDE
1216749
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-7
441996
PHARMACOLOGY OF EXTRACT - IN VITRO
CELL PROLIFERATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
368692
PHARMACOLOGY OF EXTRACT - IN VITRO
CYCLOOXYGENASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
741776
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
208450
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOQUININE B
694463
PHARMACOLOGY OF EXTRACT - IN VIVO
ALLOGRAFT REJECTION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
156668
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
FRIEDOOLEAN-3-EN-29-OIC ACID,D:A: 3-HYDROXY-2-OXO:
534149
PHARMACOLOGY OF COMPOUND - IN VITROANTIFERTILITY
SPERMICIDAL EFFECT
Tripterygium wilfordii (CELASTRACEAE)
TW-5
958078
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIMITOTIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
138492
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
AMYRIN,BETA:
1210627
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
251623
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-1-BETA RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORIC ACID B
626544
PHARMACOLOGY OF COMPOUND - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBED
ALLOGRAFT REJECTION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
1269902
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
INSECTICIDE ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
524296
TOXICITY MARKER CODEPHARMACOLOGY OF EXTRACT - IN HUMANS
DEATH
Tripterygium wilfordii (CELASTRACEAE)
694583
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
HEDERAGENIN
694259
PHARMACOLOGY OF EXTRACT - IN VITRO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
693402
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
MEDIORESINOLSYRINGARESINOLWILFORONIDE
284539
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERFERON-GAMMA SECRETION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-EN-29-OIC ACID,3-ALPHA-28-DIHYDROXY:
107907
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFORMINEWILFORIDINEWILFORZINEWILFORTRINEWILFORGINEWILFORDINE
1226622
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-6
426708
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTINEPHRITIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
607296
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIFERTILITY
SPERMICIDAL EFFECT
Tripterygium wilfordii (CELASTRACEAE)
TRIPCHLOROLIDE
1218969
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
251648
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-EN-28-OIC ACID,24-HYDROXY-3-OXO:
886589
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDENOL
269354
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-2 FORMATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE F
391052
PHARMACOLOGY OF EXTRACT - IN VIVO
TUMOR NECROSING FACTOR INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
1275523
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDE
520626
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
269377
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERFERON-GAMMA SECRETION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
HYPONINE D
519893
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
152433
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
58882
PHARMACOLOGY OF EXTRACT - IN HUMANS
CORTICOSTERONE-INDUCTION
Tripterygium wilfordii (CELASTRACEAE)
284578
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERFERON-GAMMA SECRETION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
TRIPTODIOLIDE
418520
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
958427
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTINEPHRITIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
1282364
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
ALATUSININE
207661
UV SPECTRUM GIVEN FORPLANT TISSUE CULTURE MARKER CODEMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TINGENOL,3-METHYL-23-HYDROXY-6-OXO:
647249
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1216789
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-8
631228
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1218967
PHARMACOLOGY OF EXTRACT - IN VIVOTOXICITY MARKER CODE
TOXICITY ASSESSMENT(QUANTITATIVE)
Tripterygium wilfordii (CELASTRACEAE)
148249
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTRIOLIDE,EPI:
522990
PHARMACOLOGY OF EXTRACT - IN VITRO
MUTAGENIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
269351
PHARMACOLOGY OF COMPOUND - IN VITRO
TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE F
269332
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN 8 INDUCTION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE E
248372
PHARMACOLOGY OF COMPOUND - IN VIVOISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOBENZENE M
958416
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
175542
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Tripterygium wilfordii (CELASTRACEAE)
TRIPTENOTERPENE,NEO: METHYL:
912000
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFORDINE
1216837
ANTIFERTILITYPHARMACOLOGY OF EXTRACT - IN HUMANS
SPERMICIDAL EFFECT
Tripterygium wilfordii (CELASTRACEAE)
269311
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN 8 INDUCTION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE B
424875
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
INSECTICIDE ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
831570
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
547653
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1014847
PHARMACOLOGY OF COMPOUND - IN VITRO
PROTEIN SYNTHESIS INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDETRIPTOLIDE
478687
PHARMACOLOGY OF EXTRACT - IN VITRO
INTERLEUKIN RECEPTOR EXPRESSION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
269391
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERFERON-GAMMA SECRETION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
EUONYMINE
490531
PHARMACOLOGY OF EXTRACT - IN VIVO
TESTOSTERONE LEVEL INCREASED
Tripterygium wilfordii (CELASTRACEAE)
251606
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN 8 SYNTHESIS INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
POLPUNOIC ACID
534146
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TW-2
121513
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERIFORDIN
269362
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-4 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE G
490514
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1216732
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
SPERMICIDAL EFFECT
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-4
1269948
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
INSECTICIDE ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
251617
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-2 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
DULCIOIC ACID
283727
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
AGAROFURAN,DIHYDRO: 5-ALPHA-BENZOYL-4-ALPHA-HYDROXY-1-BETA-8-ALPHA-DINICOTINOYL:
43348
PHYTOCHEMICAL SCREENING FOR
Tripterygium wilfordii (CELASTRACEAE)
O
478746
IDENTIFICATION IN BY GLCQUANTITATIVE DATA
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
251612
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
HYPODIOL
914642
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOTRITERPENE ACID A
1227527
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE,17-HYDROXY:
284506
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
KAURANE,16-ALPHA-HYDROXY-19-20-EPOXY-20(R)-HYDROXY:
694265
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTICRUSTACEAN ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
960653
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
255671
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFORLIDE A
960174
TOXICITY MARKER CODEPHARMACOLOGY OF EXTRACT - IN HUMANS
NEPHROTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
260818
X-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
FRIEDOOLEANAN-29-OIC ACID,D:A: 3-BETA-24-EPOXY-24-ALPHA-ETHOXY-2-ALPHA-HYDROXY:
381251
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIBODY FORMATION SUPPRESSION
Tripterygium wilfordii (CELASTRACEAE)
1223632
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTIANDROGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
248385
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONEDIOL
1227431
X-RAY CHRYSTALLOGRAPHIC STUDIESSYNTHESIS OF ANALOGSPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
SALASPERMIC ACID
1216775
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPCHLOROLIDE
1226628
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-28
1226601
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-3
269373
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-1-BETA RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
HYPONINE D
68515
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
534188
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TW-27
348600
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOKININ ANTAGONIST ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
43347
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
INSECTICIDE ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
156667
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
FLUOREN-9-ONE,1-HYDROXY-2-5-8-TRIMETHYL:
952486
PHARMACOLOGY OF EXTRACT - IN VITRO
INTERLEUKIN RECEPTOR EXPRESSION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
914635
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
HYPOLIDE
395409
PHARMACOLOGY OF EXTRACT - IN VITRO
INTERLEUKIN-II INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
960209
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
INSECTICIDE ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
960682
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
503741
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
284567
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-1-BETA-SYNTHESIS INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
181462
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
970555
PLANT TISSUE CULTURE MARKER CODE
Tripterygium wilfordii (CELASTRACEAE)
1226627
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-28
1216766
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2
958419
PHARMACOLOGY OF EXTRACT - IN VIVO
MUTAGENIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1269861
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
WILFORINE(CYNANCHUM)
907845
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
269333
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-2 FORMATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE E
970490
PHARMACOLOGY OF EXTRACT - IN VITRO
T-CYTOTOXIC LYMPHOCYTE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
596434
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOPHENOLIDE,ISO:
523000
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
284535
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN 8 SYNTHESIS INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-EN-29-OIC ACID,3-ALPHA-28-DIHYDROXY:
1223469
MASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFORGINE
1226603
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-3
490535
ANTIFERTILITYPHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
638324
PHARMACOLOGY OF COMPOUND - IN VITRO
LYMPHOCYTE PROLIFERATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
COMPOUND TZ-93
556654
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
284492
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-1-BETA-SYNTHESIS INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
KAURANE,16-ALPHA-HYDROXY-19-20-EPOXY-19(R)-ETHOXY:
521633
PHARMACOLOGY OF EXTRACT - IN VITRO
INTERLEUKIN-2 FORMATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
116781
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-EN-29-OIC ACID,3-BETA-22-BETA-DIHYDROXY:
694267
PHARMACOLOGY OF EXTRACT - IN VITRO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
560928
PHARMACOLOGY OF COMPOUND - IN VITRO
SPASMOLYTIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
ZEYRASTERONE,DEMETHYL:
492536
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
182955
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERIFORDIN,NEO:
269376
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-4 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
HYPONINE D
207665
PLANT TISSUE CULTURE MARKER CODEQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TINGENONE,22-HYDROXY:
521627
PHARMACOLOGY OF EXTRACT - IN VITRO
CELL PROLIFERATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
803959
PHARMACOLOGY OF EXTRACT - IN VIVO
INTERFERON-GAMMA SECRETION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
478684
PHARMACOLOGY OF EXTRACT - IN VITRO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1227546
PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1216780
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
TRIPCHLOROLIDE
1231008
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDE
251605
PHARMACOLOGY OF COMPOUND - IN VITRO
TUMOR NECROSING FACTOR INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
POLPUNOIC ACID
171427
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
WILFORMINE
352902
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
ANTIGOUT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
207659
PMR SPECTRUM REPORTEDPLANT TISSUE CULTURE MARKER CODECMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
KATONONIC ACID
1226670
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
284515
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-4 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
URS-12-EN-30-OIC ACID,22-BETA-HYDROXY-3-OXO:
858898
PLANT TISSUE CULTURE MARKER CODEISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDE
1008631
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONOLIDE
1223482
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOTRITERPENIC ACID A
269340
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-2 FORMATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORDININE I
534209
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TW-46
521632
PHARMACOLOGY OF EXTRACT - IN VITRO
CELL PROLIFERATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
251616
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-4 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
DULCIOIC ACID
269380
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-1-BETA RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
MAYTEINE
1227525
SYNTHESIS OF ANALOGSPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE,17-HYDROXY:
251632
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-EN-29-OIC ACID,22-ALPHA-HYDROXY-3-OXO:
1216740
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-6
269355
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-4 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE F
1216776
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPCHLOROLIDE
647253
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
ALLOGRAFT REJECTION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
560942
PHARMACOLOGY OF COMPOUND - IN VITRO
SPASMOLYTIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
ORTHOSPHENIC ACID
1269898
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
INSECTICIDE ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
284507
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
KAURAN-19-20-DIOIC ACID,16-ALPHA-HYDROXY:
519894
PRESENT IN (REVIEW)
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDENOL
907847
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
831576
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDE
1228030
PHARMACOLOGY OF EXTRACT - IN VIVO
INHIBIN SECRETION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
122368
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
WILFORDINE,ISO:
269395
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN 8 INDUCTION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
CONGORININE E-1
251638
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERFERON-GAMMA SECRETION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-EN-29-OIC ACID,22-ALPHA-HYDROXY-3-OXO:
284547
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN 8 SYNTHESIS INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-ENE-2-3-DIOIC ACID-3-METHYL ESTER,2-3-SECO-22-29-LACTONE
452238
QUANTITATIVE DATAIDENTIFICATION IN BY GC/MS
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
269792
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFORLIDE ATRIPTONIDETRIPTOLIDEWILFORONIDE
971151
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
INSECTICIDE ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
284589
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-2 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORIC ACID A
1187248
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
SPERMICIDAL EFFECT
Tripterygium wilfordii (CELASTRACEAE)
208453
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONOLIDE
604791
MEDICINAL FOLKLORE REPORTED FOR
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
356865
PHARMACOLOGY OF COMPOUND - IN VITRO
CELL PROLIFERATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
ZEYLASTERAL,DEMETHYL:
534172
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TW-22
961223
PHARMACOLOGY OF EXTRACT - IN VIVO
TOXIC EFFECT(GENERAL)
Tripterygium wilfordii (CELASTRACEAE)
58883
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
269309
PHARMACOLOGY OF COMPOUND - IN VITRO
TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE B
352098
PHARMACOLOGY OF EXTRACT - IN VITRO
CALCINEURIN INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
1216699
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1269866
STRUCTURE DETERMINATION OFISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFORTRINEWILFORGINEWILFORDINEWILFORINE
1226590
PHARMACOLOGY OF EXTRACT - IN VITRO
T-LYMPHOCYTE CYTOTOXICITY SUPPRESSION
Tripterygium wilfordii (CELASTRACEAE)
248381
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOBENZENE N
914638
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIMITOGENIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONOLIDE
534199
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TW-32
397834
PHARMACOLOGY OF COMPOUND - IN VITRO
LEUKOCYTE PROLIFERATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM DITERPENE LACTONE EPOXIDE D-7
910265
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
HYPOLIDE
970489
PHARMACOLOGY OF EXTRACT - IN VITRO
LYMPHOCYTE SUPPRESSION
Tripterygium wilfordii (CELASTRACEAE)
1226767
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
HYPOLIDE
744954
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
522994
PHARMACOLOGY OF EXTRACT - IN VITRO
MEMBRANE DISRUPTION EFFECT
Tripterygium wilfordii (CELASTRACEAE)
269316
PHARMACOLOGY OF COMPOUND - IN VITRO
TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE C
178959
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
WILFORMINEWILFORZINEWILFORGINE
651920
PHARMACOLOGY OF EXTRACT - IN VIVO
ALLOGRAFT REJECTION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
682595
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIGOUT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
914646
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
WILFORTRINE
490538
PHARMACOLOGY OF EXTRACT - IN HUMANS
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
534210
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TW-46
963013
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
TOXIC EFFECT(GENERAL)
Tripterygium wilfordii (CELASTRACEAE)
248408
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION AND IDENTIFICATION OF
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERIFORDIN
1223480
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
ORTHOSPHENIC ACID
248370
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOBENZENE L
269344
PHARMACOLOGY OF COMPOUND - IN VITRO
TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORDININE J
490519
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1218970
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
523004
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
911974
PMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
732032
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIALLERGENIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
158222
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE,16-HYDROXY:
176506
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFORGINE
534202
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TW-33
534194
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TW-31
534177
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TW-23
381248
PHARMACOLOGY OF EXTRACT - IN VIVO
INTERLEUKIN-1-BETA RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
573696
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFORLIDE AOLEAN-12-EN-29-OIC ACID,3-BETA-22-ALPHA-DIHYDROXY:SITOSTEROL,BETA:KATONIC ACID,2-EPI:
1228029
PHARMACOLOGY OF EXTRACT - IN VIVO
TESTOSTERONE LEVEL INCREASED
Tripterygium wilfordii (CELASTRACEAE)
960718
PHARMACOLOGY OF EXTRACT - IN VIVO
NEPHROTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1280099
PHARMACOLOGY OF COMPOUND - IN VITRO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
AGAROFURAN,DIHYDRO: 1-BETA-2-BETA-5-ALPHA-TRIACETOXY-4-ALPHA-HYDROXY-7-BETA-11-DIISO-BUTYRYL-OXY-8-ALPHA-FURANOYL:
675981
PHARMACOLOGY OF EXTRACT - IN VITRO
NITRIC OXIDE SYNTHESIS INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
712326
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIPROLIFERATION ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
389095
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
FSH LEVELS DECREASED
Tripterygium wilfordii (CELASTRACEAE)
596438
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOPHENOLIDE,ISO:
161527
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
TRIPTRIOLIDE,12-EPI:
208442
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
WILFORIC ACID B
910835
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
WILFORONIDE
1231015
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDENOL
1014851
PLANT TISSUE CULTURE MARKER CODEIDENTIFICATION IN BY TLC
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
631231
PHARMACOLOGY OF EXTRACT - IN VITRO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
284531
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERFERON-GAMMA SECRETION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-EN-29-OIC ACID,28-HYDROXY-3-OXO:
1223626
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ABORTIFACIENT EFFECT
Tripterygium wilfordii (CELASTRACEAE)
1227096
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITYREVIEW OF
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
534183
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TW-26
1227021
ANTIFERTILITYPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
534169
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TW-21
161530
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTRIOLIDE,12-EPI:
176723
CMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
FRIEDOOLEAN-3-EN-2-ON-29-OIC ACID,D:A: 3-HYDROXY:
560908
PHARMACOLOGY OF COMPOUND - IN VITRO
SPASMOLYTIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM DITERPENE 5
138502
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
POLPUNOIC ACID
694465
PHARMACOLOGY OF EXTRACT - IN VIVO
ALLOGRAFT REJECTION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
667377
PHARMACOLOGY OF EXTRACT - IN VITRO
APOPTOSIS INDUCTION
Tripterygium wilfordii (CELASTRACEAE)
1216701
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
831569
PLANT TISSUE CULTURE MARKER CODEQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
1227102
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
524297
MEDICINAL FOLKLORE REPORTED FOR
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
269384
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERFERON-GAMMA SECRETION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
MAYTEINE
958415
TOXICITY MARKER CODEPHARMACOLOGY OF EXTRACT - IN HUMANS
TOXIC EFFECT(GENERAL)
Tripterygium wilfordii (CELASTRACEAE)
363058
PHARMACOLOGY OF EXTRACT - IN VITRO
PHYSICAL CHEMICAL STUDY
Tripterygium wilfordii (CELASTRACEAE)
251609
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-2 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
POLPUNOIC ACID
352906
PHARMACOLOGY OF EXTRACT - IN VITROREVIEW OF
INTERLEUKIN-2 FORMATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
560911
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFOROL F
248412
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION AND IDENTIFICATION OF
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
MANOYL OXIDE-18-OIC ACID,13-EPI:
251610
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERFERON-GAMMA SECRETION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
POLPUNOIC ACID
251645
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-2 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
KATONIC ACID,3-EPI:
490517
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
ANTINEPHRITIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
715944
PHARMACOLOGY OF EXTRACT - IN VITRO
NUCLEAR FACTOR KAPPA-BETA INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
685905
PHARMACOLOGY OF EXTRACT - IN VITRO
LYMPHOCYTE PROLIFERATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
540370
PHARMACOLOGY OF COMPOUND - IN VITRO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
492551
PHARMACOLOGY OF EXTRACT - IN VITRO
GENOTOXICITY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
284526
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-1-BETA-SYNTHESIS INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-EN-29-OIC ACID,28-HYDROXY-3-OXO:
1216874
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
960678
PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
269365
PHARMACOLOGY OF COMPOUND - IN VITRO
TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
EBENIFOLINE E-II
269403
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-2 FORMATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONINE A#
286571
PHARMACOLOGY OF COMPOUND - IN VITRO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
WILFORMINEWILFORDCONINE
1216719
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-3
761905
PHARMACOLOGY OF EXTRACT - IN VITRO
PROTEIN EXPRESSION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
1216727
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-4
348590
PHARMACOLOGY OF EXTRACT - IN VIVO
GENE EXPRESSION INDUCTION
Tripterygium wilfordii (CELASTRACEAE)
1223486
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPCHLOROLIDE
960716
PHARMACOLOGY OF EXTRACT - IN VIVO
TOXIC EFFECT(GENERAL)
Tripterygium wilfordii (CELASTRACEAE)
1226674
PHARMACOLOGY OF EXTRACT - IN VIVO
TOXIC EFFECT(GENERAL)
Tripterygium wilfordii (CELASTRACEAE)
560925
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
PRISTIMEROL,23-NOR: DEMETHYL: 6-OXO:
138503
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
AMYRIN,BETA: 11-ALPHA-HYDROXY:
1280093
PHARMACOLOGY OF COMPOUND - IN VITRO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
AGAROFURAN,DIHYDRO: 2-BETA-3-ALPHA-7-ALPHA-8-BETA-11-PENTAACETOXY-4-ALPHA-5-ALPHA-DIHYDROXY-1-BETA-FURANOYL:AGAROFURAN,DIHYDRO: 2-BETA-5-ALPHA-7-BETA-TRIACETOXY-4-ALPHA-HYDROXY-11-ISO-BUTYRYL-OXY-1-BETA-NICOTINOYL:AGAROFURAN,DIHYDRO: 1-BETA-2-BETA-3-ALPHA-5-ALPHA-7-BETA-8-BETA-11-HEPTAACETOXY:AGAROFURAN,DIHYDRO: 1-BETA-7-BETA-8-ALPHA-TRIACETOXY-4-ALPHA-HYDROXY-2-BETA-FURANOYL-11-ISO-BUTYRYL-OXY:AGAROFURAN,DIHYDRO: 2-BETA-3-ALPHA-7-ALPHA-8-BETA-11-PENTAACETOXY-5-ALPHA-HYDROXY-1-BETA-FURFURANOYL:
907852
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1223475
MASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFORTRINE
596421
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
607299
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE,CHLORO:TRIPTODITERPENIC ACID BTRIPTODITERPENIC ACID ATRIPTOLIDE,DICHLORO:
284503
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-2 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
KAURANE,16-ALPHA-HYDROXY-19-2-EPOXY-20(R)-ETHOXY:
284556
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-2 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
KAURANE-17-19-DIOIC ACID
269791
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
URS-12-ENE-3-BETA-22-ALPHA-30-TRIOL
419130
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTILUPUS ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
970483
PLANT TISSUE CULTURE MARKER CODE
Tripterygium wilfordii (CELASTRACEAE)
724092
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
ALKALOIDS(SESQUITERPENE)
560947
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONOTERPENE METHYL ETHER
1227434
PHARMACOLOGY OF COMPOUND - IN VITRO
DNA POLYMERASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
SALASPERMIC ACID
269387
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-1-BETA RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
EUONYMINE
961218
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
607294
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIFERTILITY
SPERMICIDAL EFFECT
Tripterygium wilfordii (CELASTRACEAE)
TRIPCHLOROLIDE
352094
PHARMACOLOGY OF EXTRACT - IN VITRO
INTERLEUKIN-2 FORMATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
1220140
PHARMACOLOGY OF EXTRACT - IN HUMANS
LUPUS EFFECTS CLAIMED
Tripterygium wilfordii (CELASTRACEAE)
534166
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TW-20
519897
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDE
1269908
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
INSECTICIDE ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
248401
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOBENZENE H
68103
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
356869
PHARMACOLOGY OF COMPOUND - IN VIVO
ANGIOGENESIS INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
ZEYLASTERAL,DEMETHYL:
482638
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
251621
PHARMACOLOGY OF COMPOUND - IN VITRO
TUMOR NECROSING FACTOR INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORIC ACID B
178960
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFORINE
158225
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
251627
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
CELASTROL
269323
PHARMACOLOGY OF COMPOUND - IN VITRO
TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE D
490524
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
ANTINEPHRITIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
284524
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERFERON-GAMMA SECRETION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-ENE-22-29-LACTONE,2-ALPHA-3-BETA-DIHYDROXY:
560936
PHARMACOLOGY OF COMPOUND - IN VITRO
SPASMOLYTIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-EN-28-OIC ACID,3-ALPHA-24-DIHYDROXY:
355774
PHARMACOLOGY OF EXTRACT - IN VITRO
PHAGOCYTOSIS INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
284562
PHARMACOLOGY OF COMPOUND - IN VITRO
TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOBENZENE J
95080
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONOTERPENE
255669
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONIDE
59441
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
INSECTICIDE ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1299611
PHARMACOLOGY OF EXTRACT - IN VITRO
NITRIC OXIDE SUPPRESSION
Tripterygium wilfordii (CELASTRACEAE)
1223491
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
WILFORINE,NEO:
560931
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFOROL D
1226594
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2
596425
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDE
269401
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-1-BETA RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONINE A#
907853
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
284513
PHARMACOLOGY OF COMPOUND - IN VITRO
TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
URS-12-EN-30-OIC ACID,22-BETA-HYDROXY-3-OXO:
626536
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
284496
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-4 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
KAURANE,16-ALPHA-HYDROXY-19-20-EPOXY-19(R)-ETHOXY:
200740
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Tripterygium wilfordii (CELASTRACEAE)
TRIPTININ B
534158
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TW-14
381245
PHARMACOLOGY OF EXTRACT - IN VIVO
CELL PROLIFERATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
631233
PHARMACOLOGY OF EXTRACT - IN VITRO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
284525
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-EN-29-OIC ACID,28-HYDROXY-3-OXO:
708912
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
ZEYLASTERAL,DEMETHYL:
744955
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-1 INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
284542
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-1-12-DIEN-29-OIC ACID,2-22-BETA-DIHYDROXY-3-OXO:
596431
COMPLETE SYNTHESIS REPORTEDISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOPHENOLIDE,ISO:
674814
PHARMACOLOGY OF EXTRACT - IN VITRO
CELL ADHESION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
267584
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOBENZENE H,16-HYDROXY:
908980
PHARMACOLOGY OF EXTRACT - IN HUMANS
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
534153
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TW-6
886588
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDE
251641
PHARMACOLOGY OF COMPOUND - IN VITRO
TUMOR NECROSING FACTOR INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
KATONIC ACID,3-EPI:
248397
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION AND IDENTIFICATION OF
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
KAURAN-19-OIC ACID,16-ALPHA: 17-HYDROXY: (-):
818808
PLANT TISSUE CULTURE MARKER CODEQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
1226764
PHARMACOLOGY OF COMPOUND - IN VIVO
LYMPHOCYTE SUPPRESSION
Tripterygium wilfordii (CELASTRACEAE)
HYPOLIDE
368695
PHARMACOLOGY OF EXTRACT - IN VITRO
CYCLOOXYGENASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
960696
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
941709
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
284573
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-1-BETA-SYNTHESIS INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
TRIPTODIOLIDE
393213
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCHPLC SEPARATION DATA FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTRIOLIDEHYPOLIDETRIPTONIDE
176981
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONOTERPENE,NEO:
534190
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
TW-28
691356
PHARMACOLOGY OF EXTRACT - IN VIVO
NITRIC OXIDE SYNTHESIS INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
1223629
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
522991
PHARMACOLOGY OF EXTRACT - IN VIVO
MUTAGENIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1282363
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
EUONYMINE
694266
PHARMACOLOGY OF EXTRACT - IN VITRO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
674811
PHARMACOLOGY OF EXTRACT - IN VITRO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
534214
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TW-47
618530
VOUCHER SPECIMEN REPORTED FORYIELD IS MORE THAN 100 MGMQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
CELACINNINE
355775
PATENT DESCRIBED
Tripterygium wilfordii (CELASTRACEAE)
1231011
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
675984
PHARMACOLOGY OF EXTRACT - IN VIVO
NITRIC OXIDE SYNTHESIS INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
1226616
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
TRIPCHLOROLIDE
1216755
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-8
960715
PHARMACOLOGY OF EXTRACT - IN VIVO
TOXICITY ASSESSMENT(QUANTITATIVE)
Tripterygium wilfordii (CELASTRACEAE)
421259
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTILUPUS ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
560904
PHARMACOLOGY OF COMPOUND - IN VITRO
SPASMOLYTIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOQUINONE B
158226
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE,16-HYDROXY:
560920
PHARMACOLOGY OF COMPOUND - IN VITRO
SPASMOLYTIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
WILFOROL B
1269876
ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MEDICINAL FOLKLORE REPORTED FOR
INSECTICIDE ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1218971
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
178165
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
PHENANTHRENE,2(1H): 3-4-4(A)-9-10-10(A)-HEXAHYDRO: 8-HYDROXY-1-(HYDROXY-METHYL)-1-4(A)-DIMETHYL-7-(1-METHYL-ETHYL):
1258370
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
INSECTICIDE ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
183182
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOTRITERPENIC ACID A
421260
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1226930
PHARMACOLOGY OF EXTRACT - IN VIVO
TESTOSTERONE LEVEL DECREASED
Tripterygium wilfordii (CELASTRACEAE)
1216838
ANTIFERTILITYPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
560915
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERIGIC ACID METHYL ESTER
269369
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-4 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
EBENIFOLINE E-II
490532
PHARMACOLOGY OF EXTRACT - IN VIVO
TESTOSTERONE LEVEL DECREASED
Tripterygium wilfordii (CELASTRACEAE)
269398
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERFERON-GAMMA SECRETION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
CONGORININE E-1
284582
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-2 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOCHLOROLIDE
654651
PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS
LYMPHOCYTE PROLIFERATION STIMULATION
Tripterygium wilfordii (CELASTRACEAE)
156670
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
FUROIC ACID,3:
418524
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDE
1216715
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-2
697234
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTEDHPLC SEPARATION DATA FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
68403
PHARMACOLOGY OF EXTRACT - IN HUMANS
INTERLEUKIN-6 INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
138498
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
1216794
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-8
1269905
PHARMACOLOGY OF EXTRACT - IN VITRO
FEEDING DETERRENT(INSECT)
Tripterygium wilfordii (CELASTRACEAE)
1187253
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
992173
PLANT TISSUE CULTURE MARKER CODEISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
CELASTROLSITOSTEROL,BETA:
108018
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
ORTHOSPHENIC ACID
668768
PHARMACOLOGY OF EXTRACT - IN VITRO
LYSOZYME RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
1216733
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-5
284548
PHARMACOLOGY OF COMPOUND - IN VITRO
TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-ENE-2-3-DIOIC ACID-3-METHYL ESTER,2-3-SECO-22-29-LACTONE
1226583
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIMITOGENIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
426709
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTINEPHRITIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
960656
TOXICITY MARKER CODEPHARMACOLOGY OF EXTRACT - IN HUMANS
DEATH
Tripterygium wilfordii (CELASTRACEAE)
1299329
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOKINE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
1216759
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-8
1280118
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTEDHPLC SEPARATION DATA FOR
Tripterygium wilfordii (CELASTRACEAE)
WILFORINE
1216712
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-2
1223471
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
WILFORGINE
970497
PHARMACOLOGY OF EXTRACT - IN VITRO
INTERLEUKIN-1 FORMATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
447590
PLANT TISSUE CULTURE MARKER CODE
Tripterygium wilfordii (CELASTRACEAE)
352397
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
ZEYLASTERAL,DEMETHYL:
721432
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION OFQUANTITATIVE DATA REPORTED
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONIDETRIPTOLIDE
560907
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM DITERPENE 5
284508
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
MANOYL OXIDE-18-OIC ACID,13-EPI-19-NOR:
596424
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDE
355770
PHARMACOLOGY OF EXTRACT - IN VITRO
INTERLEUKIN 8 SYNTHESIS INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
970487
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
960707
PHARMACOLOGY OF EXTRACT - IN VIVO
TOXICITY ASSESSMENT(QUANTITATIVE)
Tripterygium wilfordii (CELASTRACEAE)
914645
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFORTRINE
248386
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOQUINONE C
207660
PLANT TISSUE CULTURE MARKER CODEMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
KAIONIC ACID,EPI:
810131
X-RAY CHRYSTALLOGRAPHIC STUDIESSTRUCTURE DETERMINATION OFISOLATION AND IDENTIFICATION AFTER CHEMICAL TREATMENT
Tripterygium wilfordii (CELASTRACEAE)
EUONYMINOL
200743
PHARMACOLOGY OF COMPOUND - IN VITRO
LEUKOTRIENE RECEPTOR BINDING EFFECT
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOQUINONE A
534142
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TW-1
1223631
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
607498
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
ZEYLASTERAL,DEMETHYL:
490528
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
704849
PHARMACOLOGY OF EXTRACT - IN VITRO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
248375
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOBENZENE M
960723
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTILUPUS ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1216779
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPCHLOROLIDE
1282352
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPFORDINE B
694464
PHARMACOLOGY OF EXTRACT - IN VIVO
ALLOGRAFT REJECTION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
284520
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN 8 SYNTHESIS INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-ENE-22-29-LACTONE,2-ALPHA-3-BETA-DIHYDROXY:
95084
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOPHENOLIDE METHYL ETHERHYPOLIDETRIPTOPHENOLIDE,NEO:TRIPTOLIDENOLTRIPTOPHENOL
284566
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
LABD-TRANS-13-ENE-8-ALPHA-15-DIOLTRIPTERININ
914630
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
ABIETA-8-11-13-TRIEN-3-ONE,14-HYDROXY:
251635
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-1-BETA RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-EN-29-OIC ACID,22-ALPHA-HYDROXY-3-OXO:
269312
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-2 FORMATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE B
284555
PHARMACOLOGY OF COMPOUND - IN VITRO
TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
KAURANE-17-19-DIOIC ACID
284502
PHARMACOLOGY OF COMPOUND - IN VITRO
TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
KAURANE,16-ALPHA-HYDROXY-19-2-EPOXY-20(R)-ETHOXY:
397831
PHARMACOLOGY OF COMPOUND - IN VITRO
LEUKOCYTE PROLIFERATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
59445
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFORGINE
269392
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
CONGORININE E-1
1228025
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
693831
PHARMACOLOGY OF EXTRACT - IN VITRO
APOPTOSIS INDUCTION
Tripterygium wilfordii (CELASTRACEAE)
1216748
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-7
460630
PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
910834
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRITOPHENOLIDE,ISO-NEO:
694584
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
LEUKOTRIENE ANTAGONIST ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
HEDERAGENIN
251598
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
ABRUSLACTONE A
534145
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TW-2
534148
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
TW-5
960667
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
ANTILUPUS ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1226598
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-3
668769
PHARMACOLOGY OF EXTRACT - IN VITRO
BETA-GLUCURONIDASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
152437
CMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPCHLOROLIDE
1226606
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPCHLOROLIDE
521638
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-2 FORMATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
248393
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
KAURAN-19-OIC ACID,16-ALPHA-HYDROXY: (-):
251624
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-4 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORIC ACID B
138495
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
FRIEDO-29-NOR-OLEAN-24-OIC ACID,D:A: 22-BETA-HYDROXY-3-21-DIOXO: METHYL ESTER
560919
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFOROL B
248295
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFORMINEWILFORTRINEWILFORDINE,ISO:WILFORDINEALATUSININEWILFORINE
284519
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-1-BETA-SYNTHESIS INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-ENE-22-29-LACTONE,2-ALPHA-3-BETA-DIHYDROXY:
1269899
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
INSECTICIDE ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1216762
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2
960692
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIASTHMATIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
958414
TOXICITY MARKER CODEPHARMACOLOGY OF EXTRACT - IN HUMANS
LEUKOPENIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
255672
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
ACETANILIDE,PARA-ETHOXY:
284577
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-4 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
TRIPTODIOLIDE
490516
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
391051
PHARMACOLOGY OF EXTRACT - IN VIVO
CELL PROLIFERATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
269370
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERFERON-GAMMA SECRETION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
EBENIFOLINE E-II
1049938
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
WILFORLIDE B
952490
PHARMACOLOGY OF EXTRACT - IN VITRO
LYMPHOCYTE(B) STIMULATION
Tripterygium wilfordii (CELASTRACEAE)
560918
PHARMACOLOGY OF COMPOUND - IN VITRO
SPASMOLYTIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
WILFOROL A
914629
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIMITOGENIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
ABIETA-8-11-13-TRIEN-3-ONE,11-HYDROXY-14-METHOXY:
960710
PHARMACOLOGY OF EXTRACT - IN VIVO
NEPHROTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
818807
PLANT TISSUE CULTURE MARKER CODEQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDE
178379
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
WILFORDSINE
1269865
STRUCTURE DETERMINATION OFPMR SPECTRUM REPORTEDISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFORZINEWILFORGINEWILFORINE
176716
CMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
ZEYLASTERONE,DEMETHYL:
1282367
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
CHUCHUHUSNINE E-V,7-EPI: 4-HYDROXY:
694262
PHARMACOLOGY OF EXTRACT - IN VITRO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
269381
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN 8 INDUCTION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
MAYTEINE
1216751
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-7
278360
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFORINE
1226612
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
TRIPCHLOROLIDE
1226928
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
59449
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFORTRINE
426722
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
856925
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Tripterygium wilfordii (CELASTRACEAE)
FRIEDELAN-29-OIC ACID,3-24-DIOXO:
959879
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
732033
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
912001
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFORGINE
709403
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPCHLOROLIDE
473342
PHARMACOLOGY OF EXTRACT - IN VITRO
T-LYMPHOCYTE SUPPRESSION
Tripterygium wilfordii (CELASTRACEAE)
1177545
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTICOAGULANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
478688
PHARMACOLOGY OF EXTRACT - IN VITRO
INTERLEUKIN-2 FORMATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
269301
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE A
960719
PHARMACOLOGY OF EXTRACT - IN HUMANS
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1294991
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1216722
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-3
395759
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
284536
PHARMACOLOGY OF COMPOUND - IN VITRO
TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-EN-29-OIC ACID,3-ALPHA-28-DIHYDROXY:
1216737
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-5
251600
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
FRIEDOOLEAN-3-EN-29-OIC ACID,D:A: 3-HYDROXY-2-OXO:
1226623
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-6
1269949
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
INSECTICIDE ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
560950
PHARMACOLOGY OF COMPOUND - IN VITRO
SPASMOLYTIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
WILFOROL E
490521
PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS
ANTINEPHRITIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
958425
PHARMACOLOGY OF EXTRACT - IN VIVO
ANALGESIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
596428
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDE
1216791
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-8
1226587
PHARMACOLOGY OF EXTRACT - IN VITRO
T-LYMPHOCYTE SUPPRESSION
Tripterygium wilfordii (CELASTRACEAE)
1216783
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-6
770606
REVIEW OF
Tripterygium wilfordii (CELASTRACEAE)
68046
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIALZHEIMER'S ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
248382
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOBENZENE N
269402
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN 8 INDUCTION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONINE A#
519890
PRESENT IN (REVIEW)REVIEW OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPCHLOROLIDE
418065
IDENTIFICATION IN BY TLCQUANTITATIVE DATA
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
1227529
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE,17-HYDROXY:
1216744
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-6
1275522
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDENOL
1223490
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
ANTHRAQUINONE,1-8-DIHYDROXY-4-HYDROXYMETHYL:
269350
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE F
1216772
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-3
1226602
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-3
152434
MASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDE
534161
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TW-19
958253
TOXICITY MARKER CODEPHARMACOLOGY OF EXTRACT - IN HUMANS
TOXIC EFFECT(GENERAL)
Tripterygium wilfordii (CELASTRACEAE)
1175312
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTINEPHROTOXIC
Tripterygium wilfordii (CELASTRACEAE)
284514
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-2 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
URS-12-EN-30-OIC ACID,22-BETA-HYDROXY-3-OXO:
283726
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
AGAROFURAN,DIHYDRO: 1-BETA-2-BETA-5-ALPHA-11-TETRAACETOXY-8-ALPHA-BENZOYL-4-ALPHA-HYDROXY-7-BETA-NICOTINOYL:
418521
PMR SPECTRUM REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDE
911996
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE
1218968
PHARMACOLOGY OF EXTRACT - IN VIVOTOXICITY MARKER CODE
TOXICITY ASSESSMENT(QUANTITATIVE)
Tripterygium wilfordii (CELASTRACEAE)
914641
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIHISTAMINE ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOTRITERPENE ACID A
260819
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
BI-2(H)-BENZOPYRAN]-4-4'-DIOL,3-3': [3-3'-4-4'-TETRAHYDRO-6-6'-DIMETHOXY:
1226681
MEDICINAL FOLKLORE REPORTED FOR
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
426713
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
269305
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-2 FORMATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE A
175543
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONOTERPENE,12-METHOXY:
1216704
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
SPERMICIDAL EFFECT
Tripterygium wilfordii (CELASTRACEAE)
248379
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOBENZENE N
352896
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1282356
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
WILFORINE
970493
PHARMACOLOGY OF EXTRACT - IN VITRO
LYMPHOCYTE(B) SUPPRESSION
Tripterygium wilfordii (CELASTRACEAE)
647247
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
534156
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TW-7
958404
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
907846
ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MEDICINAL FOLKLORE REPORTED FOR
ANTILEPROTIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
547652
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
502495
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
958077
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIMITOTIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
284546
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-1-BETA-SYNTHESIS INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-ENE-2-3-DIOIC ACID-3-METHYL ESTER,2-3-SECO-22-29-LACTONE
688621
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFORLIDE ASALASPERMIC ACIDKATONIC ACID,3-EPI:TRIPTERYGONECANGORONINREGELIN,DEMETHYL:TRIPTOTRITERPENIC ACID AREGELINFRIEDEL-3-EN-20-ALPHA-OIC ACID,3-HYDROXY-2-OXO:WILFORLIDE B
284551
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERFERON-GAMMA SECRETION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-ENE-2-3-DIOIC ACID-3-METHYL ESTER,2-3-SECO-22-29-LACTONE
121510
PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERIFORDIN
1037183
PLANT TISSUE CULTURE MARKER CODEPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDECELASTROLTRIPTOLIDE
1210626
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ESTROUS CYCLE DISRUPTION EFFECT
Tripterygium wilfordii (CELASTRACEAE)
932311
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTINEPHRITIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
284585
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
CORSOLIC ACIDWILFORLIDE ATRIPTOTRITERPENIC ACID BLABD-14-EN-19-OIC AICD,14-15-DIHYDROXY-8-13-EPOXY:REGEOL C
459287
PLANT TISSUE CULTURE MARKER CODEIDENTIFICATION IN BY HPLC
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDEABIETIC ACID,DEHYDRO:TRIPTOLIDE
560939
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
SALASPERMIC ACID
352097
PHARMACOLOGY OF EXTRACT - IN VITRO
INTERLEUKIN RECEPTOR EXPRESSION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
284534
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-1-BETA-SYNTHESIS INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-EN-29-OIC ACID,3-ALPHA-28-DIHYDROXY:
914628
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
ABIETA-8-11-13-TRIEN-3-ONE,11-HYDROXY-14-METHOXY:
971152
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
INSECTICIDE ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
534167
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TW-20
178170
UV SPECTRUM GIVEN FORX-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLACTONE
95081
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONOTERPENE,NEO:
1226929
PHARMACOLOGY OF EXTRACT - IN VIVO
TESTOSTERONE LEVEL DECREASED
Tripterygium wilfordii (CELASTRACEAE)
1230997
PHARMACOLOGY OF EXTRACT - IN VITROANTIFERTILITY
SPERMICIDAL EFFECT
Tripterygium wilfordii (CELASTRACEAE)
352897
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
251626
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERFERON-GAMMA SECRETION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORIC ACID B
66981
PHARMACOLOGY OF EXTRACT - IN HUMANS
MISCELLANEOUS EFFECTS
Tripterygium wilfordii (CELASTRACEAE)
269364
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
EBENIFOLINE E-II
970496
PHARMACOLOGY OF EXTRACT - IN VITRO
IMMUNOGLOBULIN PRODUCTION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
534150
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TW-5
353571
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
251604
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
POLPUNOIC ACID
178168
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOQUINONE C
910279
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDENOL
1226673
PHARMACOLOGY OF EXTRACT - IN VIVO
TOXIC EFFECT(GENERAL)
Tripterygium wilfordii (CELASTRACEAE)
284512
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN 8 SYNTHESIS INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
URS-12-EN-30-OIC ACID,22-BETA-HYDROXY-3-OXO:
78863
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOTRITERPENIC ACID A
534231
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE,15-HYDROXY:
696986
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCHPLC SEPARATION DATA FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
87220
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
WILFORIDINE
1216726
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-4
958412
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
269345
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-1-BETA RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORDININE J
1226683
PHARMACOLOGY OF EXTRACT - IN VITROANTIFERTILITY
SPERMICIDAL EFFECT
Tripterygium wilfordii (CELASTRACEAE)
1219010
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ESTROUS CYCLE DISRUPTION EFFECT
Tripterygium wilfordii (CELASTRACEAE)
703951
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
699025
PHARMACOLOGY OF EXTRACT - IN VITRO
CELL PROLIFERATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
1216777
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPCHLOROLIDE
960654
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
522485
IDENTIFICATION IN BY TLCWORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATA
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
1155551
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTIIMPLANTATION EFFECT
Tripterygium wilfordii (CELASTRACEAE)
963014
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1216767
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
SPERMICIDAL EFFECT
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2
714665
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
SALASPERMIC ACIDOLEANA-1-3-5(10)-6-9(11)-PENTAEN-29-OIC ACID,D: A-FRIEDO: 24-25-DINOR: 2-3-DIHYDROXY-8-METHYL:OLEAN-12-EN-29-OIC ACID,3-BETA-22-ALPHA-DIHYDROXY:ZEYLASTERAL,DEMETHYL:ORTHOSPHENIC ACIDFRIEDEL-3-ENE-20-ALPHA-OIC ACID,3-HYDROXY-2-OXO:CELASTROLCANGORONINEOLEAN-12-EN-29-OIC ACID,3-DETA-22-BETA-DIHYDROXY:POLPUNONIC ACIDPOLPUNONIC ACID,2-HYDROXY:
1218972
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
138493
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
ABIETA-8-11-13-TRIEN-3-ALPHA-OL,12-METHOXY:
534178
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TW-25
1280096
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
AGAROFURAN,DIHYDRO: 1-BETA-7-BETA-8-ALPHA-TRIACETOXY-4-ALPHA-HYDROXY-2-BETA-FURANOYL-11-ISO-BUTYRYL-OXY:
283725
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
AGAROFURAN,DIHYDRO: 1-BETA-5-ALPHA-11-TRIACETOXY-7-BETA-BENZOYL-4-ALPHA-HYDROXY-8-BETA-NICOTINOYL:
1216730
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-4
1227519
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPCHLOROLIDE
397829
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
284538
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-4 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-EN-29-OIC ACID,3-ALPHA-28-DIHYDROXY:
544122
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
560929
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFOROL C
251622
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN 8 SYNTHESIS INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORIC ACID B
960712
PHARMACOLOGY OF EXTRACT - IN VIVO
TOXIC EFFECT(GENERAL)
Tripterygium wilfordii (CELASTRACEAE)
269324
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-1-BETA RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE D
534227
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE,15-HYDROXY:
426712
ANTIFERTILITYPHARMACOLOGY OF EXTRACT - IN HUMANS
MENSTRUATION INHIBITION EFFECT
Tripterygium wilfordii (CELASTRACEAE)
1226619
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-6
1282355
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFORINE
1227024
PHARMACOLOGY OF EXTRACT - IN VIVO
TOXIC EFFECT(GENERAL)
Tripterygium wilfordii (CELASTRACEAE)
1216700
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1187249
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
SPERMICIDAL EFFECT
Tripterygium wilfordii (CELASTRACEAE)
176722
CMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
CANGORONINE
674816
PHARMACOLOGY OF EXTRACT - IN VITRO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1231007
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
SPERMICIDAL EFFECT
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDE
960684
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
251611
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
DULCIOIC ACID
208448
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERIGIC ACID METHYL ESTER
1226766
PHARMACOLOGY OF COMPOUND - IN VIVO
COMPLEMENT INDUCTION EFFECT
Tripterygium wilfordii (CELASTRACEAE)
HYPOLIDE
352907
PHARMACOLOGY OF EXTRACT - IN VITROREVIEW OF
INTERFERON-GAMMA SECRETION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
626537
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
284527
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN 8 SYNTHESIS INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-EN-29-OIC ACID,28-HYDROXY-3-OXO:
560912
PHARMACOLOGY OF COMPOUND - IN VITRO
SPASMOLYTIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
WILFOROL F
560930
PHARMACOLOGY OF COMPOUND - IN VITRO
SPASMOLYTIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
WILFOROL C
540371
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDE
727385
X-RAY CHRYSTALLOGRAPHIC STUDIESSTRUCTURE DETERMINATION OFPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFORLIDE A
1119845
PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
762794
PHARMACOLOGY OF EXTRACT - IN VITRO
CALCIUM CHANNEL BLOCKER
Tripterygium wilfordii (CELASTRACEAE)
1227524
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIFERTILITY
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE,15-HYDROXY:
1187255
PHARMACOLOGY OF EXTRACT - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
503742
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
952487
PHARMACOLOGY OF EXTRACT - IN VITRO
INTERLEUKIN RECEPTOR EXPRESSION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
459395
PLANT TISSUE CULTURE MARKER CODEISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-EN-29-OIC ACID,22-BETA-HYDROXY-3-OXO:
368691
PHARMACOLOGY OF EXTRACT - IN VITRO
CYCLOOXYGENASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
58884
PHARMACOLOGY OF EXTRACT - IN VITRO
LYMPHOCYTE TRANSFORMATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
255665
X-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONE
626532
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
INTERLEUKIN-II INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
616165
VOUCHER SPECIMEN REPORTED FORPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONIDE
970482
PHARMACOLOGY OF EXTRACT - IN VITRO
INTERLEUKIN RECEPTOR EXPRESSION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
1302917
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
269379
PHARMACOLOGY OF COMPOUND - IN VITRO
TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
MAYTEINE
251637
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-2 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-EN-29-OIC ACID,22-ALPHA-HYDROXY-3-OXO:
279040
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOTIN L
419129
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTILUPUS ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
910425
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
HYPOLIDE
512084
PHARMACOLOGY OF EXTRACT - IN HUMANS
IMMUNOLOGIC EFFECTS(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
183181
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOTRITERPENIC ACID A
284491
X-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
KAURANE,16-ALPHA-HYDROXY-19-20-EPOXY-19(R)-ETHOXY:
618531
PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORMASS-SPECTRAL FRAGMENTATION REPORTEDYIELD IS MORE THAN 100 MGMQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Tripterygium wilfordii (CELASTRACEAE)
CELAFURINE
631232
PHARMACOLOGY OF EXTRACT - IN VITRO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1269907
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
INSECTICIDE ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
207656
PMR SPECTRUM REPORTEDPLANT TISSUE CULTURE MARKER CODECMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOCALLIC ACID A
155401
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
WILFORCIDINE
1226396
QUANTITATIVE DATA REPORTEDISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFORGINETRIPTOLIDE
352093
PHARMACOLOGY OF EXTRACT - IN VITRO
CELL PROLIFERATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
284530
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-4 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-EN-29-OIC ACID,28-HYDROXY-3-OXO:
560901
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONOTERPENOL
560948
PHARMACOLOGY OF COMPOUND - IN VITRO
SPASMOLYTIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONOTERPENE METHYL ETHER
355771
PHARMACOLOGY OF EXTRACT - IN VITRO
TUMOR NECROSING FACTOR INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
255668
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERIFORDIN
1227545
PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
667376
PHARMACOLOGY OF EXTRACT - IN VITRO
COLONY FORMATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
914639
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOTRITERPENE ACID A
851695
PRESENT IN (REVIEW)PLANT TISSUE CULTURE MARKER CODE
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDEOLEANOLIC ACIDCELASTROLSITOSTEROL,BETA:POLPUNONIC ACID
267583
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOCALLINE,6-ALPHA-HYDROXY:
907854
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
914643
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTODIHYDROXY ACID METHYL ESTER
251608
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-4 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
POLPUNOIC ACID
284501
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN 8 SYNTHESIS INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
KAURANE,16-ALPHA-HYDROXY-19-2-EPOXY-20(R)-ETHOXY:
284516
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERFERON-GAMMA SECRETION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
URS-12-EN-30-OIC ACID,22-BETA-HYDROXY-3-OXO:
269368
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-2 FORMATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
EBENIFOLINE E-II
251642
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN 8 SYNTHESIS INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
KATONIC ACID,3-EPI:
1216723
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-3
873210
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
286572
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFORMINE
534159
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TW-14
129584
UV SPECTRUM GIVEN FORX-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTRIOLIDE
251615
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-1-BETA RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
DULCIOIC ACID
1226620
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-6
207655
PMR SPECTRUM REPORTEDPLANT TISSUE CULTURE MARKER CODECMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOCALLOL
251633
PHARMACOLOGY OF COMPOUND - IN VITRO
TUMOR NECROSING FACTOR INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-EN-29-OIC ACID,22-ALPHA-HYDROXY-3-OXO:
284541
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-20(30)-DIENE,21-BETA-28-DIHYDROXY-3-OXO: 29-NOR:
1216763
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2
534205
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TW-36
914632
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIMITOGENIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONIDE
1280092
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
AGAROFURAN,DIHYDRO: 2-BETA-3-ALPHA-7-ALPHA-8-BETA-11-PENTAACETOXY-4-ALPHA-5-ALPHA-DIHYDROXY-1-BETA-FURANOYL:
279042
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOBENZENE H,16-HYDROXY:
269329
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE E
1231014
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDENOL
269348
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-4 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORDININE J
907848
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONIDE
534197
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TW-32
492499
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
161528
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTRIOLIDE,12-EPI:
534164
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TW-19
1269932
PHARMACOLOGY OF EXTRACT - IN VIVO
TOXIC EFFECT(GENERAL)
Tripterygium wilfordii (CELASTRACEAE)
1228028
PHARMACOLOGY OF EXTRACT - IN VIVO
TESTOSTERONE LEVEL DECREASED
Tripterygium wilfordii (CELASTRACEAE)
560937
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
FRIEDOOLEAN-5-ENE,D:B: 3-BETA-29-DIHYDROXY:
960711
PHARMACOLOGY OF EXTRACT - IN VIVO
TOXIC EFFECT(GENERAL)
Tripterygium wilfordii (CELASTRACEAE)
1227433
PHARMACOLOGY OF COMPOUND - IN VITRO
REVERSE TRANSCRIPTASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
SALASPERMIC ACID
960700
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDEWILFORINE
1014848
PHARMACOLOGY OF COMPOUND - IN VITRO
RNA SYNTHESIS INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDETRIPTOLIDE
607295
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
TRIPCHLOROLIDE
1014850
PLANT TISSUE CULTURE MARKER CODEIDENTIFICATION IN BY TLC
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDETRIPTOLIDE
1227521
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
TRIPCHLOROLIDE
1223627
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTIIMPLANTATION EFFECT
Tripterygium wilfordii (CELASTRACEAE)
457656
PHYTOCHEMICAL SCREENING FORQUANTITATIVE DATA
Tripterygium wilfordii (CELASTRACEAE)
O
534186
PHARMACOLOGY OF COMPOUND - IN VITROANTIFERTILITY
SPERMICIDAL EFFECT
Tripterygium wilfordii (CELASTRACEAE)
TW-27
521626
PHARMACOLOGY OF EXTRACT - IN VITRO
CELL PROLIFERATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
520625
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
534175
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TW-23
961224
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
284523
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-4 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-ENE-22-29-LACTONE,2-ALPHA-3-BETA-DIHYDROXY:
269308
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE B
638325
PHARMACOLOGY OF COMPOUND - IN VITRO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
COMPOUND TZ-93
356864
PHARMACOLOGY OF COMPOUND - IN VITRO
CELL PROLIFERATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
ZEYLASTERAL,DEMETHYL:
476146
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
389097
PHARMACOLOGY OF EXTRACT - IN VIVO
TESTOSTERONE LEVEL DECREASED
Tripterygium wilfordii (CELASTRACEAE)
1189162
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
SPERMICIDAL EFFECT
Tripterygium wilfordii (CELASTRACEAE)
766506
REVIEW OF
Tripterygium wilfordii (CELASTRACEAE)
1223474
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
WILFORINE
492552
PHARMACOLOGY OF EXTRACT - IN VITRO
GENOTOXICITY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1226609
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPCHLOROLIDE
958405
PHARMACOLOGY OF EXTRACT - IN VIVO
CLASTOGENIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1226762
ANTIFERTILITYPHARMACOLOGY OF EXTRACT - IN HUMANS
MENSTRUATION INHIBITION EFFECT
Tripterygium wilfordii (CELASTRACEAE)
352903
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
522995
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM TOTAL DITERPENES
348601
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
421262
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1282366
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
CHUCHUHUSNINE E-V,7-EPI: 4-HYDROXY:
269319
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-2 FORMATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE C
523003
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1216788
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
SPERMICIDAL EFFECT
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-6
534189
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TW-28
560922
PHARMACOLOGY OF COMPOUND - IN VITRO
SPASMOLYTIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
CELASTROL
200739
PHARMACOLOGY OF COMPOUND - IN VITRO
LEUKOTRIENE RECEPTOR BINDING EFFECT
Tripterygium wilfordii (CELASTRACEAE)
TRIPTININ A
732031
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1216741
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-6
1227100
PHARMACOLOGY OF EXTRACT - IN HUMANS
TESTOSTERONE LEVEL DECREASED
Tripterygium wilfordii (CELASTRACEAE)
439818
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
352396
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
ZEYLASTERAL,DEMETHYL:
269334
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-4 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE E
178164
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM QUINONE 11
709405
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-6 FORMATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
TRIPCHLOROLIDE
958418
PHARMACOLOGY OF EXTRACT - IN VIVO
MUTAGENIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1226763
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDCORRECTION OF STRUCTUREQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
HYPOLIDE
152435
MASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDENOL
1228031
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPOUND TW-27
1147951
PLANT TISSUE CULTURE MARKER CODEWORK DESCRIBED MAINLY CONCERNS METHODOLOGY
Tripterygium wilfordii (CELASTRACEAE)
208441
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
WILFORIC ACID A
596435
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOPHENOLIDE,ISO:
389096
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
LH-SYNTHESIS INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
269386
PHARMACOLOGY OF COMPOUND - IN VITRO
TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
EUONYMINE
490534
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
911999
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFORINE
568972
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDE
534228
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE,15-HYDROXY:
269359
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-1-BETA RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE G
1216875
ANTIFERTILITYPHARMACOLOGY OF EXTRACT - IN HUMANS
MENSTRUATION INHIBITION EFFECT
Tripterygium wilfordii (CELASTRACEAE)
912002
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFORTINE
364730
DEPARTMENTAL MARKER CODE. NO DATA CODED
Tripterygium wilfordii (CELASTRACEAE)
1227101
PHARMACOLOGY OF EXTRACT - IN HUMANS
TESTOSTERONE LEVEL INCREASED
Tripterygium wilfordii (CELASTRACEAE)
490512
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTINEPHRITIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
459396
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-EN-29-OIC ACID,22-ALPHA-HYDROXY-3-OXO:OLEAN-12-EN-29-OIC ACID,3-BETA-22-ALPHA-DIHYDROXY:OLEAN-12-EN-29-OIC ACID,3-BETA-22-BETA-DIHYDROXY:
284554
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN 8 SYNTHESIS INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
KAURANE-17-19-DIOIC ACID
348599
PHARMACOLOGY OF EXTRACT - IN VITRO
CELL PROLIFERATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
284545
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-ENE-2-3-DIOIC ACID-3-METHYL ESTER,2-3-SECO-22-29-LACTONE
269397
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-4 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
CONGORININE E-1
685904
PHARMACOLOGY OF EXTRACT - IN VIVO
ALLOGRAFT REJECTION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
418523
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
613721
COMPLETE SYNTHESIS REPORTEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
138497
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-ENE,3-BETA-29-DIHYDROXY:
596414
PLANT TISSUE CULTURE MARKER CODE
Tripterygium wilfordii (CELASTRACEAE)
1014849
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTIMITOTIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDETRIPTOLIDE
1226597
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2
1223485
X-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPCHLOROLIDE
630727
PHARMACOLOGY OF EXTRACT - IN VITRO
CELL ADHESION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
958431
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1150098
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
992172
PLANT TISSUE CULTURE MARKER CODEQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDE
1269906
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
INSECTICIDE ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
596427
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDE
958076
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
251619
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFORIC ACID B
534136
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONOTERPENE METHYL ETHERTRIPTONOTERPENE
911973
PMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONIDE
248405
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION AND IDENTIFICATION OF
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERIFORDIN
208455
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
HYPOLIDE
960697
PHARMACOLOGY OF EXTRACT - IN HUMANS
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
704850
PHARMACOLOGY OF EXTRACT - IN VITRO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
284504
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-4 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
KAURANE,16-ALPHA-HYDROXY-19-2-EPOXY-20(R)-ETHOXY:
1312842
CLINICAL STUDIESREVIEW OF
HYPOTENSIVE ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
293543
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
WILFORDLONGINE
129585
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTRIOLIDE
418064
IDENTIFICATION IN BY TLCQUANTITATIVE DATA
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
654649
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIBODY FORMATION SUPPRESSION
Tripterygium wilfordii (CELASTRACEAE)
560944
PHARMACOLOGY OF COMPOUND - IN VITRO
SPASMOLYTIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
CANGORONIN
910278
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONOTERPENE METHYL ETHER
138488
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-EN-29-OIC ACID,22-ALPHA-HYDROXY-3-OXO:
129839
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE,16-HYDROXY:
560933
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
OLEANOLIC ACID,3-ACETOXY:
1226626
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-28
426732
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
INSECTICIDE ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
534160
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TW-14
200744
UV SPECTRUM GIVEN FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
ABIETA-3-8-11-13-TETRAEN-19-OIC ACID,11-HYDROXY-14-METHOXY-19(4-3)-ABEO:
668765
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
473243
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTEDHPLC SEPARATION DATA FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONIDETRIPTOLIDE
1218965
PHARMACOLOGY OF EXTRACT - IN VIVOTOXICITY MARKER CODE
TOXIC EFFECT(GENERAL)
Tripterygium wilfordii (CELASTRACEAE)
1269965
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
GLUCOSEFRUCTOSECELASTROLDULCITOL
248376
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOBENZENE M
1216705
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-1
523002
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITYREVIEW OF
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
1269931
PHARMACOLOGY OF EXTRACT - IN VITRO
CARDIOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
970492
PHARMACOLOGY OF EXTRACT - IN VITRO
T-LYMPHOCYTE SUPPRESSION
Tripterygium wilfordii (CELASTRACEAE)
603771
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
958409
PHARMACOLOGY OF EXTRACT - IN HUMANS
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
695740
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
MISCELLANEOUS EFFECTS
Tripterygium wilfordii (CELASTRACEAE)
182954
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERIFORDIN,NEO:
176504
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONINE B
534212
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TW-47
1216752
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-7
397832
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM DITERPENE LACTONE EPOXIDE D-7
284561
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN 8 SYNTHESIS INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOBENZENE J
1226927
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
352911
PHARMACOLOGY OF EXTRACT - IN VIVO
GONADAL TOXICITY
Tripterygium wilfordii (CELASTRACEAE)
1227542
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
534171
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TW-21
356868
PHARMACOLOGY OF COMPOUND - IN VIVO
ANGIOGENESIS INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
ZEYLASTERAL,DEMETHYL:
1216747
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-7
1274916
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFORLIDE ASALASPERMIC ACIDFLUOR-9-ENONE,1-HYDROXY-2-5-8-TRIMETHYL:KATONIC ACID,3-EPI:FRIEDEL-3-ENE-20-ALPHA-CARBOXYLIC ACID,3-HYDROXY-2-OXO:CANGORONINEFRIEDOOLEAN-5-ENE,D:B: 3-BETA-29-DIHYDROXY:
284581
PHARMACOLOGY OF COMPOUND - IN VITRO
TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOCHLOROLIDE
247099
X-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOTIN ATRIPTOTIN B
963009
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITYREVIEW OF
ANTIIMPLANTATION EFFECT
Tripterygium wilfordii (CELASTRACEAE)
460631
PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
176714
CMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
PRISTIMEROL,23-NOR: 6-OXO-DEMETHYL:
534147
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TW-5
1216795
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
SPERMICIDAL EFFECT
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-8
1303000
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOMODULATOR ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
560926
PHARMACOLOGY OF COMPOUND - IN VITRO
SPASMOLYTIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
PRISTIMEROL,23-NOR: DEMETHYL: 6-OXO:
1226624
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-6
284586
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-1-BETA-SYNTHESIS INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORIC ACID A
1226605
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-3
744956
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-2 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
886587
PHARMACOLOGY OF COMPOUND - IN HUMANSANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDETRIPTOLIDE
1187252
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
284537
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-2 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-EN-29-OIC ACID,3-ALPHA-28-DIHYDROXY:
458670
PLANT TISSUE CULTURE MARKER CODEMICROBIAL TRANSFORMATION OF
Tripterygium wilfordii (CELASTRACEAE)
CEMBRA-TRANS-2-TRANS-7-TRANS-11-TRIENE-4(S)-6(R)-DIOL,1(S):CEMBRA-TRANS-3-TRANS-7-TRANS-11-TRIENE-4(R)-6(R)-DIOL,1(S):
1216708
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-1
1269911
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
INSECTICIDE ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
WILFORDINEWILFORINE
1226586
PHARMACOLOGY OF EXTRACT - IN VITRO
INTERLEUKIN RECEPTOR EXPRESSION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
607298
X-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE,16-HYDROXY:
1216784
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-6
1216745
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
SPERMICIDAL EFFECT
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-6
762167
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION OFQUANTITATIVE DATA REPORTED
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONIDETRIPTOLIDE
1269964
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
CELASTROL
269352
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-1-BETA RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE F
1013521
MEDICINAL FOLKLORE REPORTED FOR
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
163359
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONOTERPENE
534201
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TW-33
520628
PHARMACOLOGY OF EXTRACT - IN VIVO
LIPID PEROXIDE FORMATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
404971
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
SYRINGARESINOL,(-):
269371
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
HYPONINE D
519891
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
TRIPCHLOROLIDE
1275521
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE,16-HYDROXY:
352900
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
911995
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE
534213
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TW-47
1216787
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-6
251647
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
ORTHOSPHENIC ACID
421266
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
284572
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERFERON-GAMMA SECRETION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
958252
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
248416
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOQUINONE BTRIPTOTIN BKAURANE,16-ALPHA-19-DIHYDROXY: ENT:HINOKIOLTRIPTOQUINONE ATRIPTOBENZENE ATRIPTININ B
490527
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
960677
PHARMACOLOGY OF EXTRACT - IN VITRO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1155549
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
SPERMICIDAL EFFECT
Tripterygium wilfordii (CELASTRACEAE)
209434
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Tripterygium wilfordii (CELASTRACEAE)
TRIPTETRAOLIDE,NEO:
1227097
ANTIFERTILITYPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
478685
PHARMACOLOGY OF EXTRACT - IN VITRO
CELL PROLIFERATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
694263
PHARMACOLOGY OF EXTRACT - IN VITRO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
452237
QUANTITATIVE DATAIDENTIFICATION IN BY GC/MS
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
269382
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-2 FORMATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
MAYTEINE
269330
PHARMACOLOGY OF COMPOUND - IN VITRO
TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE E
699024
PHARMACOLOGY OF EXTRACT - IN VITRO
CELL PROLIFERATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
355769
PHARMACOLOGY OF EXTRACT - IN VITRO
INTERLEUKIN-6 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
269313
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-4 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE B
1226613
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
TRIPCHLOROLIDE
532253
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
HYPOLIDE METHYL ETHERTRIPTOPHENOLIDE,ISO-NEO:TRIPTONOLIDEWILFORONIDE
269393
PHARMACOLOGY OF COMPOUND - IN VITRO
TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
CONGORININE E-1
901672
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOTRITERPENIC ACID C
269302
PHARMACOLOGY OF COMPOUND - IN VITRO
TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE A
14568
PMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONIDE
284550
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-4 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-ENE-2-3-DIOIC ACID-3-METHYL ESTER,2-3-SECO-22-29-LACTONE
121511
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
171426
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFORMINE
932310
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTINEPHRITIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
269341
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-4 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORDININE I
534144
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TW-2
764213
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ESTROGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
1216734
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-5
596430
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDE
596418
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
284549
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-2 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-ENE-2-3-DIOIC ACID-3-METHYL ESTER,2-3-SECO-22-29-LACTONE
43346
ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MEDICINAL FOLKLORE REPORTED FOR
INSECTICIDE ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
618532
PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREYIELD IS LESS THAN 50 MGM
Tripterygium wilfordii (CELASTRACEAE)
CELABENZINE
884666
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTINEPHRITIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
421269
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTINEPHRITIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
715943
PHARMACOLOGY OF EXTRACT - IN VITRO
ACTIVATOR PROTEIN 1 INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
631234
PHARMACOLOGY OF EXTRACT - IN VITRO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1216790
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-8
355766
PHARMACOLOGY OF EXTRACT - IN VITRO
INTERLEUKIN-2 FORMATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
255670
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
1017382
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
1216711
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
SPERMICIDAL EFFECT
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-1
960693
PHARMACOLOGY OF EXTRACT - IN HUMANS
TOXIC EFFECT(GENERAL)
Tripterygium wilfordii (CELASTRACEAE)
395408
PHARMACOLOGY OF COMPOUND - IN VITRO
IMMUNODEPRESSIVE ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
ZEYLESTERAL,DEMETHYL:
478480
PHARMACOLOGY OF EXTRACT - IN VITRO
PEROXIDE FORMATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
248398
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION AND IDENTIFICATION OF
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
KAURAN-19-OIC ACID,16-ALPHA: 17-HYDROXY: (-):
960683
PHARMACOLOGY OF EXTRACT - IN VIVO
TOXICITY ASSESSMENT(QUANTITATIVE)
Tripterygium wilfordii (CELASTRACEAE)
478744
IDENTIFICATION IN BY GLCQUANTITATIVE DATA
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
503739
PHARMACOLOGY OF EXTRACT - IN VITRO
INTERLEUKIN-6 FORMATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
674813
PHARMACOLOGY OF EXTRACT - IN VITRO
CELL ADHESION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
560900
PHARMACOLOGY OF COMPOUND - IN VITRO
SPASMOLYTIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
HYPOLIDE
1258371
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
INSECTICIDE ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
248409
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
MANOYL OXIDE-18-OIC ACID,13-EPI:
647252
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
596423
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDE
284509
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
ABIETA-8-11-13-TRIENE,3-BETA-11-19-TRIHYDROXY-14-METHOXY:
961227
PHARMACOLOGY OF EXTRACT - IN VIVO
TOXICITY ASSESSMENT(QUANTITATIVE)
Tripterygium wilfordii (CELASTRACEAE)
534230
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE,15-HYDROXY:
248387
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION AND IDENTIFICATION OF
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOQUINONE C
1216773
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-3
626542
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
560941
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
ORTHOSPHENIC ACID
521637
PHARMACOLOGY OF COMPOUND - IN VITRO
CELL PROLIFERATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
914640
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOTRITERPENE ACID A
269320
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-4 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE C
1216756
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-8
1223630
PHARMACOLOGY OF EXTRACT - IN VIVO
TOXIC EFFECT(GENERAL)
Tripterygium wilfordii (CELASTRACEAE)
607499
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
ZEYLASTERAL,DEMETHYL:
421258
TOXICITY MARKER CODEPHARMACOLOGY OF EXTRACT - IN HUMANS
NEPHROTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
269375
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-2 FORMATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
HYPONINE D
694268
PHARMACOLOGY OF EXTRACT - IN VITRO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
208452
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOBENZENE A
604792
MEDICINAL FOLKLORE REPORTED FOR
ANTIPRURITIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
59448
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
INSECTICIDE ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
WILFORDINE
426721
PHARMACOLOGY OF EXTRACT - IN VITRO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
856924
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CELL PROLIFERATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
CELASTROL
1226682
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1226615
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
TRIPCHLOROLIDE
1282351
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPFORDINE B
284565
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERFERON-GAMMA SECRETION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOBENZENE J
1226591
PHARMACOLOGY OF EXTRACT - IN VITRO
NATURAL KILLER CELL INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
1226931
PHARMACOLOGY OF EXTRACT - IN VIVO
TOXIC EFFECT(GENERAL)
Tripterygium wilfordii (CELASTRACEAE)
534155
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TW-7
208444
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOBENZENE H
626533
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
CELL PROLIFERATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
269326
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-2 FORMATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE D
568543
IDENTIFICATION IN BY TLC
Tripterygium wilfordii (CELASTRACEAE)
HYPOLIDECELASTROL
1269900
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
INSECTICIDE ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1226671
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1210625
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
1216716
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-2
573192
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
176717
CMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
CELASTROL
958424
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANALGESIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
248392
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION AND IDENTIFICATION OF
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOQUINONE C
534206
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TW-42
958397
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
178158
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
WILFOROL E
729573
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOMODULATOR ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
176721
CMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
FRIEDOOLEAN-5-ENE,D:B: 3-BETA-29-DIHYDROXY:
381246
PHARMACOLOGY OF EXTRACT - IN VIVO
INTERLEUKIN-2 FORMATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
708913
PHARMACOLOGY OF COMPOUND - IN VIVO
TOXICITY ASSESSMENT(QUANTITATIVE)
Tripterygium wilfordii (CELASTRACEAE)
ZEYLASTERAL,DEMETHYL:
181461
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE,16-HYDROXY:
269356
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE F
1049939
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
SITOSTEROL,BETA:DAUCOSTEROL
1216760
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
SPERMICIDAL EFFECT
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-8
269360
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN 8 INDUCTION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE G
269337
PHARMACOLOGY OF COMPOUND - IN VITRO
TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORDININE I
1227520
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIFERTILITY
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
TRIPCHLOROLIDE
208449
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOQUINONE A
984269
PMR SPECTRUM REPORTEDISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONIDE
284576
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-2 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
TRIPTODIOLIDE
14567
PHARMACOLOGY OF EXTRACT - IN VITROX-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDABSOLUTE CONFIGURATION DETERMINEDCORRECTION OF STRUCTUREISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
1269862
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFORDINE
1226672
PHARMACOLOGY OF EXTRACT - IN VIVO
TOXICITY ASSESSMENT(QUANTITATIVE)
Tripterygium wilfordii (CELASTRACEAE)
958413
PHARMACOLOGY OF EXTRACT - IN HUMANS
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
960655
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
59450
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
INSECTICIDE ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
WILFORTRINE
1231012
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE,18-HYDROXY:
1269929
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
INSECTICIDE ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
960672
PHARMACOLOGY OF EXTRACT - IN VITRO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
178378
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
WILFORDSINE
251618
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERFERON-GAMMA SECRETION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
DULCIOIC ACID
1269903
PHARMACOLOGY OF EXTRACT - IN VITRO
FEEDING DETERRENT(INSECT)
Tripterygium wilfordii (CELASTRACEAE)
1223484
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFORLIDE A
607500
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
ZEYLASTERAL,DEMETHYL:
521630
PHARMACOLOGY OF EXTRACT - IN VITRO
CELL PROLIFERATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
960674
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
208446
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
CELASTROL
1223477
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
WILFORTRINE
352395
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
ZEYLASTERAL,DEMETHYL:
293542
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFORGINE
907850
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
426720
PHARMACOLOGY OF EXTRACT - IN VITRO
PROSTAGLANDIN INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
560905
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOQUINONE C
176720
CMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-EN-28-OIC ACID,3-ALPHA-24-DIHYDROXY:
1216742
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-6
515049
HPLC DATA REPORTEDIDENTIFICATION IN BY HPLCQUANTITATIVE DATA
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
248294
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
WILFORDININE HWILFORDININE GWILFORDININE FWILFORDININE DWILFORDININE E
978502
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1269896
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
INSECTICIDE ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
248403
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION AND IDENTIFICATION OF
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERIFORDIN
269385
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
EUONYMINE
152432
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONIDE
1082625
ANTIFERTILITYPHARMACOLOGY OF EXTRACT - IN HUMANS
MENSTRUATION INHIBITION EFFECT
Tripterygium wilfordii (CELASTRACEAE)
1216731
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-4
1282360
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFORDINE
534140
PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
278359
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Tripterygium wilfordii (CELASTRACEAE)
WILFORDSUINE
284494
PHARMACOLOGY OF COMPOUND - IN VITRO
TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
KAURANE,16-ALPHA-HYDROXY-19-20-EPOXY-19(R)-ETHOXY:
911998
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
WILFORMINE
534168
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TW-20
269304
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN 8 INDUCTION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE A
607292
UV SPECTRUM GIVEN FORX-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPCHLOROLIDE
519895
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDENOL
952492
PHARMACOLOGY OF EXTRACT - IN VITRO
LYMPHOCYTE(B) STIMULATION
Tripterygium wilfordii (CELASTRACEAE)
1227025
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
352096
PHARMACOLOGY OF EXTRACT - IN VITRO
PROTEIN TYROSINE KINASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
534193
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TW-28
348591
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1283523
PHARMACOLOGY OF EXTRACT - IN VIVO
NITRIC OXIDE SYNTHASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
1227436
PLANT TISSUE CULTURE MARKER CODEIDENTIFICATION IN BY TLC
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDEWILFORLIDE AOLEANOLIC ACIDKATONIC ACID,3-EPI:TRIPTONIDETRIPTOLIDE
284522
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-2 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-ENE-22-29-LACTONE,2-ALPHA-3-BETA-DIHYDROXY:
280622
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
KAURANE,19-20-EPOXY-16-HYDROXY:
352898
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
960688
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTINEPHRITIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
269390
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-4 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
EUONYMINE
970495
PHARMACOLOGY OF EXTRACT - IN VITRO
INTERLEUKIN-2 FORMATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
284498
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
KAURANE,16-ALPHA-HYDROXY-19-20-EPOXY-19(S)-ETHOXY:
269310
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-1-BETA RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE B
1082624
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1171842
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
1226761
ANTIFERTILITYPHARMACOLOGY OF EXTRACT - IN HUMANS
MENSTRUATION INHIBITION EFFECT
Tripterygium wilfordii (CELASTRACEAE)
708911
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
ZEYLASTERAL,DEMETHYL:
1280095
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
AGAROFURAN,DIHYDRO: 2-BETA-3-ALPHA-7-ALPHA-8-BETA-11-PENTAACETOXY-5-ALPHA-HYDROXY-1-BETA-FURFURANOYL:
1226608
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPCHLOROLIDE
284553
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-1-BETA-SYNTHESIS INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
KAURANE-17-19-DIOIC ACID
284587
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN 8 SYNTHESIS INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORIC ACID A
958401
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
251601
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-EN-28-OIC ACID,23-HYDROXY-3-OXO:
161529
PHARMACOLOGY OF COMPOUND - IN VIVO
TOXICITY ASSESSMENT(QUANTITATIVE)
Tripterygium wilfordii (CELASTRACEAE)
TRIPTRIOLIDE,12-EPI:
1148114
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
WILFORLIDE A
960689
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTINEPHRITIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
535910
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOQUINOLOL
1155550
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ABORTIFACIENT EFFECT
Tripterygium wilfordii (CELASTRACEAE)
1216736
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-5
284540
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
FRIEDELAN METHYL ESTER,29-NOR: 2-BETA-22-BETA-DIHYDROXY-3-21-DIOXO-24-CARBOXYL:
856922
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFORLIDE ASALASPERMIC ACIDKATONIC ACID,3-EPI:WILFORLIDE BOLEAN-12-EN-29-OIC ACID,3-BETA-22-(A)-DIHYDROXY:
178159
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONOTERPENE METHYL ETHER
521636
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-2 FORMATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDE
886586
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
368690
PHARMACOLOGY OF EXTRACT - IN VITRO
CYCLOOXYGENASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
279043
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOTIN J
704851
PHARMACOLOGY OF EXTRACT - IN VITRO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1304117
CLINICAL STUDIESREVIEW OF
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
423040
PLANT TISSUE CULTURE MARKER CODEWORK DESCRIBED MAINLY CONCERNS METHODOLOGY
Tripterygium wilfordii (CELASTRACEAE)
269328
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERFERON-GAMMA SECRETION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE D
439817
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1258373
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
INSECTICIDE ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
534179
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TW-25
395410
PHARMACOLOGY OF EXTRACT - IN VITRO
PROSTAGLANDIN E2 INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
14566
X-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDABSOLUTE CONFIGURATION DETERMINEDCORRECTION OF STRUCTUREQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
695498
PHARMACOLOGY OF EXTRACT - IN VIVO
MACROPHAGE INFLAMMATORY PROTEIN-2 REDUCTION
Tripterygium wilfordii (CELASTRACEAE)
1218973
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
269339
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN 8 INDUCTION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORDININE I
1226629
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-28
647248
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
907456
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
138494
UV SPECTRUM GIVEN FORX-RAY CHRYSTALLOGRAPHIC STUDIESQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TINGENONE
534182
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TW-26
666518
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1280097
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
AGAROFURAN,DIHYDRO: 2-BETA-5-ALPHA-7-BETA-TRIACETOXY-4-ALPHA-HYDROXY-11-ISO-BUTYRYL-OXY-1-BETA-NICOTINOYL:
421263
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
284575
PHARMACOLOGY OF COMPOUND - IN VITRO
TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
TRIPTODIOLIDE
284569
PHARMACOLOGY OF COMPOUND - IN VITRO
TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
1216771
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-3
958428
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTINEPHRITIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
1231006
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDE
1223470
PHARMACOLOGY OF COMPOUND - IN VIVO
TOXICITY ASSESSMENT(QUANTITATIVE)
Tripterygium wilfordii (CELASTRACEAE)
WILFORGINE
761903
PHARMACOLOGY OF EXTRACT - IN VITRO
NITRIC OXIDE RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
729579
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
ANTIFERTILITY ACTIVITY(MALE)
Tripterygium wilfordii (CELASTRACEAE)
DITERPENE TW-19
161532
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTRIOLIDE,12-EPI:
1223628
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
560902
PHARMACOLOGY OF COMPOUND - IN VITRO
SPASMOLYTIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONOTERPENOL
284528
PHARMACOLOGY OF COMPOUND - IN VITRO
TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-EN-29-OIC ACID,28-HYDROXY-3-OXO:
1227023
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
958417
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
269315
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE C
961220
PHARMACOLOGY OF EXTRACT - IN VIVO
APPETITE SUPPRESSANT
Tripterygium wilfordii (CELASTRACEAE)
251607
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-1-BETA RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
POLPUNOIC ACID
269367
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN 8 INDUCTION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
EBENIFOLINE E-II
1274915
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Tripterygium wilfordii (CELASTRACEAE)
SALASPERMIC ACID-3-ETHYL ETHER
327575
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
ANTITUMOR ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDETRIPTONIDETRIPTOLIDE
1223495
IDENTIFICATION IN BY TLCQUANTITATIVE DATA REPORTED
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
620939
PHARMACOLOGY OF EXTRACT - IN VIVO
PROSTAGLANDIN E2 INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
352908
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
TOXICITY ASSESSMENT(QUANTITATIVE)
Tripterygium wilfordii (CELASTRACEAE)
703952
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
429021
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTINEPHROTOXIC
Tripterygium wilfordii (CELASTRACEAE)
490515
PHARMACOLOGY OF EXTRACT - IN HUMANS
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
960690
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTILUPUS ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
960685
PHARMACOLOGY OF EXTRACT - IN VIVO
ANALGESIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
534185
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
TW-27
1282362
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
EUONYMINE
540369
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
251614
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN 8 SYNTHESIS INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
DULCIOIC ACID
958407
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
284558
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERFERON-GAMMA SECRETION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
KAURANE-17-19-DIOIC ACID
138487
PLANT TISSUE CULTURE MARKER CODEQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDE
251634
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN 8 SYNTHESIS INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-EN-29-OIC ACID,22-ALPHA-HYDROXY-3-OXO:
560923
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
ZEYRASTERAL,DEMETHYL
1017381
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
200738
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Tripterygium wilfordii (CELASTRACEAE)
TRIPTININ A
1226589
PHARMACOLOGY OF EXTRACT - IN VITRO
T-CYTOTOXIC LYMPHOCYTE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
657061
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOLOGIC EFFECTS(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
59443
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFORINE
503740
PHARMACOLOGY OF EXTRACT - IN VITRO
CARNITINE PALMITOYL TRANSFERASE-I INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
667742
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
58885
PHARMACOLOGY OF EXTRACT - IN VITRO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
907849
PHARMACOLOGY OF EXTRACT - IN VIVO
TOXICITY ASSESSMENT(QUANTITATIVE)
Tripterygium wilfordii (CELASTRACEAE)
616164
PHARMACOLOGY OF COMPOUND - IN VIVOVOUCHER SPECIMEN REPORTED FORPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
ANTITUMOR ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDE
395406
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
ZEYLESTERAL,DEMETHYL:
709404
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPCHLOROLIDE
970481
PHARMACOLOGY OF EXTRACT - IN VITRO
CELL CYCLE CYTOTOXICITY(G1 PHASE)
Tripterygium wilfordii (CELASTRACEAE)
1269933
PHARMACOLOGY OF EXTRACT - IN VIVO
TOXIC EFFECT(GENERAL)
Tripterygium wilfordii (CELASTRACEAE)
269378
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
MAYTEINE
534163
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TW-19
39369
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
560938
PHARMACOLOGY OF COMPOUND - IN VITRO
SPASMOLYTIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
FRIEDOOLEAN-5-ENE,D:B: 3-BETA-29-DIHYDROXY:
200741
PHARMACOLOGY OF COMPOUND - IN VITRO
LEUKOTRIENE RECEPTOR BINDING EFFECT
Tripterygium wilfordii (CELASTRACEAE)
TRIPTININ B
1150096
PHARMACOLOGY OF EXTRACT - IN VIVO
LYMPHOCYTE TRANSFORMATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
960709
PHARMACOLOGY OF EXTRACT - IN VIVO
TOXIC EFFECT(GENERAL)
Tripterygium wilfordii (CELASTRACEAE)
251636
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-4 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-EN-29-OIC ACID,22-ALPHA-HYDROXY-3-OXO:
1187251
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
492534
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
952494
PHARMACOLOGY OF EXTRACT - IN VITRO
INTERLEUKIN-1 FORMATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
961225
PHARMACOLOGY OF EXTRACT - IN VIVO
TOXIC EFFECT(GENERAL)
Tripterygium wilfordii (CELASTRACEAE)
255667
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
BICYCLO(3,3,0)-OCTANE,3-7-DIOXA: 6-OXO-2-(4'-HYDROXY-3'-5'-DIMETHOXY-PHENYL): (DL):
284490
VOUCHER SPECIMEN REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
284583
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-4 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOCHLOROLIDE
175541
VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONOTERPENE,NEO:
604793
MEDICINAL FOLKLORE REPORTED FOR
WOUND HEALING ACCELERATION
Tripterygium wilfordii (CELASTRACEAE)
269325
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN 8 INDUCTION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE D
59446
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
INSECTICIDE ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
WILFORGINE
1216758
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-8
152436
MASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE,16-HYDROXY:
269389
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-2 FORMATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
EUONYMINE
355772
PHARMACOLOGY OF EXTRACT - IN VITRO
INTERLEUKIN-1 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
95082
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONODIOL
284564
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-4 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOBENZENE J
352894
REVIEW OF
Tripterygium wilfordii (CELASTRACEAE)
426711
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTINEPHRITIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
251625
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-2 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORIC ACID B
521624
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1269868
UV SPECTRUM GIVEN FORISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
WILFORTRINEWILFORGINE
356867
PHARMACOLOGY OF COMPOUND - IN VITRO
CELL MIGRATION EFFECT
Tripterygium wilfordii (CELASTRACEAE)
ZEYLASTERAL,DEMETHYL:
1230996
PHARMACOLOGY OF EXTRACT - IN VITROANTIFERTILITY
SPERMICIDAL EFFECT
Tripterygium wilfordii (CELASTRACEAE)
971153
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
INSECTICIDE ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1189163
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
1226765
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
HYPOLIDE
534174
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TW-22
39368
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
952495
PHARMACOLOGY OF EXTRACT - IN VITRO
T-LYMPHOCYTE SUPPRESSION
Tripterygium wilfordii (CELASTRACEAE)
78864
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOTRITERPENIC ACID A
626538
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
ALLOGRAFT REJECTION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
522996
PLANT TISSUE CULTURE MARKER CODE
Tripterygium wilfordii (CELASTRACEAE)
1119844
PLANT TISSUE CULTURE MARKER CODEIDENTIFICATION IN BY HPLC
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDE
1216725
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
SPERMICIDAL EFFECT
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-3
284511
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-1-BETA-SYNTHESIS INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
URS-12-EN-30-OIC ACID,22-BETA-HYDROXY-3-OXO:
87221
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFORTRINEWILFORGINEWILFORDINEWILFORINE
530270
PHARMACOLOGY OF EXTRACT - IN VIVO
LYMPHOCYTE PROLIFERATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
348602
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
675983
PHARMACOLOGY OF EXTRACT - IN VIVO
NITRIC OXIDE SYNTHESIS INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
176718
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
WILFOROL C
269346
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN 8 INDUCTION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORDININE J
952484
PHARMACOLOGY OF EXTRACT - IN VITRO
T-LYMPHOCYTE SUPPRESSION
Tripterygium wilfordii (CELASTRACEAE)
248391
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION AND IDENTIFICATION OF
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOQUINONE C
251643
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-1-BETA RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
KATONIC ACID,3-EPI:
960706
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
522998
REVIEW OF
Tripterygium wilfordii (CELASTRACEAE)
258052
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
KATONIC ACID,3-EPI:
523006
IDENTIFICATION IN BY TLCWORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATA REPORTED
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
425713
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTINEPHRITIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
1216768
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-3
963011
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
LEUKOPENIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
490529
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
1187254
PHARMACOLOGY OF EXTRACT - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1282359
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
WILFORJINE
181458
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE,16-HYDROXY:
596436
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOPHENOLIDE,ISO:
958080
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTILUPUS ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
960680
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSTIMULANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
178162
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
HYPOLIDE
534196
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TW-31
269307
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERFERON-GAMMA SECRETION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE A
478478
PHARMACOLOGY OF EXTRACT - IN VITRO
RADICAL SCAVENGING EFFECT
Tripterygium wilfordii (CELASTRACEAE)
560916
PHARMACOLOGY OF COMPOUND - IN VITRO
SPASMOLYTIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERIGIC ACID METHYL ESTER
1228027
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTIFSH ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
129838
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE,16-HYDROXY:
910837
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONOLIDE
521635
PHARMACOLOGY OF COMPOUND - IN VITRO
CELL PROLIFERATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDE
694260
PHARMACOLOGY OF EXTRACT - IN VITRO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
490533
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
596416
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
284533
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-EN-29-OIC ACID,3-ALPHA-28-DIHYDROXY:
200745
PHARMACOLOGY OF COMPOUND - IN VITRO
LEUKOTRIENE RECEPTOR BINDING EFFECT
Tripterygium wilfordii (CELASTRACEAE)
ABIETA-3-8-11-13-TETRAEN-19-OIC ACID,11-HYDROXY-14-METHOXY-19(4-3)-ABEO:
426731
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
INSECTICIDE ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1218966
PHARMACOLOGY OF EXTRACT - IN VIVOTOXICITY MARKER CODE
TOXIC EFFECT(GENERAL)
Tripterygium wilfordii (CELASTRACEAE)
1216753
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
SPERMICIDAL EFFECT
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-7
560949
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFOROL E
248380
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOBENZENE N
970486
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDE
58880
PHARMACOLOGY OF EXTRACT - IN HUMANS
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
208457
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM QUINONE 11
704847
PHARMACOLOGY OF EXTRACT - IN VITRO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1216782
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-6
138500
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
OLEANOLIC ACID
269374
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN 8 INDUCTION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
HYPONINE D
1226618
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPCHLOROLIDE
251603
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
WILFORIC ACID F
521629
PHARMACOLOGY OF EXTRACT - IN VITRO
CELL PROLIFERATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
207663
PLANT TISSUE CULTURE MARKER CODEQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
CELASTROL
116779
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGONE
560913
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFORLIDE A
978503
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
207657
PMR SPECTRUM REPORTEDPLANT TISSUE CULTURE MARKER CODECMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOCALLIC ACID B
352904
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
478686
MEDICINAL FOLKLORE REPORTED FOR
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1189161
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
269405
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERFERON-GAMMA SECRETION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONINE A#
492501
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
269363
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERFERON-GAMMA SECRETION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE G
560927
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
ZEYRASTERONE,DEMETHYL:
522992
PHARMACOLOGY OF EXTRACT - IN VIVO
MUTAGENIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1216793
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-8
491818
IDENTIFICATION IN BY TLCWORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATA REPORTED
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
251630
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-EN-28-OIC ACID,29-HYDROXY-3-OXO:
704848
PHARMACOLOGY OF EXTRACT - IN VITRO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
958075
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
283728
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
REGELIDINE
1216769
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-3
492493
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1216785
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-6
1226585
PHARMACOLOGY OF EXTRACT - IN VITRO
CELL CYCLE CYTOTOXICITY(M PHASE)
Tripterygium wilfordii (CELASTRACEAE)
478745
IDENTIFICATION IN BY GLCQUANTITATIVE DATA
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
534204
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TW-36
148248
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTRIOLIDE,EPI:
269357
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE G
519898
PRESENT IN (REVIEW)
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE,16-HYDROXY:
492535
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1227544
PHARMACOLOGY OF EXTRACT - IN VITRO
TESTOSTERONE LEVEL INCREASED
Tripterygium wilfordii (CELASTRACEAE)
520627
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
284505
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERFERON-GAMMA SECRETION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
KAURANE,16-ALPHA-HYDROXY-19-2-EPOXY-20(R)-ETHOXY:
251629
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-EN-29-OIC ACID,22-BETA-HYDROXY-3-OXO:
248384
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOBENZENE N
831574
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDE
251646
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERFERON-GAMMA SECRETION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
KATONIC ACID,3-EPI:
1275520
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDE,2-EPI:
914647
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
WILFORTRINE
260817
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
FRIEDO-3-NOR-2-3-SECO-OLEANANE-2-29-DIOIC ACID,D: A: 4-OXO:
958074
PHARMACOLOGY OF EXTRACT - IN HUMANS
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
207662
UV SPECTRUM GIVEN FORPLANT TISSUE CULTURE MARKER CODEMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TINGENOL,3-METHYL-22-BETA-23-DIHYDROXY-6-OXO:
1226600
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-3
1228032
PHARMACOLOGY OF COMPOUND - IN VITROANTIFERTILITY
FERTILIZATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPOUND TW-27
909526
PHARMACOLOGY OF EXTRACT - IN VITRO
DNA SYNTHESIS INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
248377
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOBENZENE M
176503
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONINE A
1269966
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
CELASTROLDULCITOL
703929
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
960669
TOXICITY MARKER CODEPHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
TOXIC EFFECT(GENERAL)
Tripterygium wilfordii (CELASTRACEAE)
1226599
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-3
560934
PHARMACOLOGY OF COMPOUND - IN VITRO
SPASMOLYTIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
OLEANOLIC ACID,3-ACETOXY:
534211
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TW-46
352910
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITYREVIEW OF
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
534170
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TW-21
914636
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIMITOGENIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
HYPOLIDE
59442
PHARMACOLOGY OF EXTRACT - IN VIVOTOXICITY MARKER CODE
TOXIC EFFECT(GENERAL)
Tripterygium wilfordii (CELASTRACEAE)
397833
PHARMACOLOGY OF COMPOUND - IN VITRO
RADICAL SCAVENGING EFFECT
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM DITERPENE LACTONE EPOXIDE D-7
656950
PHARMACOLOGY OF EXTRACT - IN VITRO
PROSTAGLANDIN SYNTHESIS INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
269318
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN 8 INDUCTION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE C
626534
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
CELL PROLIFERATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
460632
PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
284570
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-2 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
284544
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
FRIEDOOLEAN-29-OIC ACID,24-NOR-D: A: 2-3-DIHYDROXY-1-3-5(10)-7-TETRAENE-6-ALPHA(1'-HYDROXY-ETHYL):
958406
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1284228
PHARMACOLOGY OF EXTRACT - IN VIVO
ACTH-INDUCTION
Tripterygium wilfordii (CELASTRACEAE)
1150097
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
222359
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Tripterygium wilfordii (CELASTRACEAE)
TRIPTETRAOLIDE,DICHLORO:
421452
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFORLIDE A
540521
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
SALASPERMIC ACIDTRIPTOTRITERPENOIC ACID AWILFORLIDE B
1226596
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2
1187250
ANTIFERTILITYPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
1299602
HPLC DATA REPORTED
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM POLYSACCHARIDES
530271
PHARMACOLOGY OF EXTRACT - IN VIVO
LYMPHOCYTE PROLIFERATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
381247
PHARMACOLOGY OF EXTRACT - IN VIVO
INTERFERON-GAMMA SECRETION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
540372
PHARMACOLOGY OF COMPOUND - IN VITRO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDE
248395
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION AND IDENTIFICATION OF
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
KAURAN-19-OIC ACID,16-ALPHA: 17-HYDROXY: (-):
248400
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION AND IDENTIFICATION OF
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
KAURAN-19-OIC ACID,16-ALPHA: 17-HYDROXY: (-):
175915
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONOTERPENE METHYL ETHERTRIPTONOTERPENETRIPTOLIDENOL
269342
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERFERON-GAMMA SECRETION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORDININE I
284591
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERFERON-GAMMA SECRETION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORIC ACID A
952488
PHARMACOLOGY OF EXTRACT - IN VITRO
INTERLEUKIN-2 FORMATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
524447
PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1216764
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2
208456
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
MAYTENOIC ACID
355776
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTITUMOR ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1226926
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
490518
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
ANTIPSORIATIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
495644
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
694264
PHARMACOLOGY OF EXTRACT - IN VITRO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
534229
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE,15-HYDROXY:
959877
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
ANTINEPHRITIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
1216757
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-8
182953
PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERIFORDIN,NEO:
910277
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONOTERPENE
667379
PHARMACOLOGY OF EXTRACT - IN VITRO
IMMUNOLOGIC EFFECTS(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
269383
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-4 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
MAYTEINE
1258372
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
INSECTICIDE ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1020183
PLANT TISSUE CULTURE MARKER CODEQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDE
178167
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
108017
PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIC ACID A
269331
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-1-BETA RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE E
503737
PHARMACOLOGY OF EXTRACT - IN VITRO
INTERLEUKIN-1 FORMATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
147389
ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Tripterygium wilfordii (CELASTRACEAE)
EILFORJINETRIPTOTETRAOLIDE
521625
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
490530
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
492553
PHARMACOLOGY OF EXTRACT - IN VITRO
GENOTOXICITY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
129840
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE,16-HYDROXY:
176713
UV SPECTRUM GIVEN FORX-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
WILFOROL B
208445
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOBENZENE I
269303
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-1-BETA RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE A
1216717
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-2
961219
PHARMACOLOGY OF EXTRACT - IN VIVO
APPETITE SUPPRESSANT
Tripterygium wilfordii (CELASTRACEAE)
970491
PHARMACOLOGY OF EXTRACT - IN VITRO
T-LYMPHOCYTE SUPPRESSION
Tripterygium wilfordii (CELASTRACEAE)
958421
PHARMACOLOGY OF EXTRACT - IN HUMANS
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
284580
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN 8 SYNTHESIS INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOCHLOROLIDE
1235300
VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
CELACINNINE
418522
PMR SPECTRUM REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDENOL
478479
PHARMACOLOGY OF EXTRACT - IN VITRO
SUPEROXIDE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
960717
PHARMACOLOGY OF EXTRACT - IN VIVO
NEPHROTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1226621
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-6
1280791
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOREACTIVITY INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
1226676
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1216724
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-3
1216729
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-4
1223488
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
TRIPCHLOROLIDE
1269947
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
INSECTICIDE ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1216735
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-5
534143
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TW-1
490536
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1226768
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
HYPOLIDE
960670
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
153512
ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Tripterygium wilfordii (CELASTRACEAE)
GLUT-5-ENE-3-BETA-28-DIOLURSANE-3-BETA-5-ALPHA-DIOL
176980
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONOTERPENE,12-METHOXY:
831571
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
534207
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TW-42
607297
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
TOXIC EFFECT(GENERAL)
Tripterygium wilfordii (CELASTRACEAE)
TRIPCHLOROLIDE
626543
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ALLOGRAFT REJECTION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
1216710
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
ANTISPERMATOGENIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-1
647251
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
534139
PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
352909
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
TOXICITY ASSESSMENT(QUANTITATIVE)
Tripterygium wilfordii (CELASTRACEAE)
1269912
UV SPECTRUM GIVEN FORISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
WILFORDINEWILFORINE
269353
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN 8 INDUCTION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE F
656949
PHARMACOLOGY OF EXTRACT - IN VITRO
CYCLOOXYGENASE 2 INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
1014845
PHARMACOLOGY OF EXTRACT - IN VITROPLANT TISSUE CULTURE MARKER CODEIDENTIFICATION IN BY TLCANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDETRIPTOLIDE
283724
PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
AGAROFURAN,DIHYDRO: 1-BETA-2-BETA-5-ALPHA-8-BETA-11-PENTAACETOXY-4-ALPHA-HYDROXY-3-ALPHA-(2'-METHYL-BUTANOYL)-15-NICOTINOYL-7-OXO:
248388
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION AND IDENTIFICATION OF
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOQUINONE C
1223492
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFORTRINE
386080
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
PERITASSINE A
14572
X-RAY CHRYSTALLOGRAPHIC STUDIESPHARMACOLOGY OF COMPOUND - IN VIVOMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDE
1171843
PHARMACOLOGY OF EXTRACT - IN VIVO
TESTOSTERONE LEVEL DECREASED
Tripterygium wilfordii (CELASTRACEAE)
519892
PRESENT IN (REVIEW)
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
560945
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
FRIEDOOLEAN-3-EN-2-ON-29-OIC ACID,D: A: 3-HYDROXY:
596422
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
66813
PHARMACOLOGY OF EXTRACT - IN HUMANS
MISCELLANEOUS EFFECTS
Tripterygium wilfordii (CELASTRACEAE)
831572
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
284497
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERFERON-GAMMA SECRETION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
KAURANE,16-ALPHA-HYDROXY-19-20-EPOXY-19(R)-ETHOXY:
1227432
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
SALASPERMIC ACID
1216774
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
SPERMICIDAL EFFECT
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-3
408111
X-RAY CHRYSTALLOGRAPHIC STUDIESPHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
ANTITUMOR ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDETRIPTOLIDE
668766
PHARMACOLOGY OF EXTRACT - IN VITRO
PROSTAGLANDIN INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
490537
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTINEPHRITIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
1037182
PLANT TISSUE CULTURE MARKER CODEPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDECELASTROLTRIPTOLIDE
803958
PHARMACOLOGY OF EXTRACT - IN VIVO
INTERLEUKIN-4 RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
452236
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDWORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORIDENTIFICATION IN BY GC/MS
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
490526
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
158223
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE,16-HYDROXY:
1223481
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
ORTHOSPHENIC ACID
107909
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
WILFORTRINE,1-DEACETYL:
208451
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOPHENOLIDE,NEO:
910263
ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOPHENOLIDE METHYL ETHER
963010
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITYREVIEW OF
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
248373
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOBENZENE M
1299613
PHARMACOLOGY OF EXTRACT - IN VITRO
NITRIC OXIDE SUPPRESSION
Tripterygium wilfordii (CELASTRACEAE)
1282354
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPFORDINE C
534151
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TW-5
958402
PHARMACOLOGY OF EXTRACT - IN HUMANS
NEPHROTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1226592
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2
284500
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-1-BETA-SYNTHESIS INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
KAURANE,16-ALPHA-HYDROXY-19-2-EPOXY-20(R)-ETHOXY:
269314
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERFERON-GAMMA SECRETION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE B
534154
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TW-6
269394
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-1-BETA RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
CONGORININE E-1
300572
ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOPHENOLIDE,NEO: 11-O-BETA-D-GLUCOPYRANOSIDE
67545
PHARMACOLOGY OF EXTRACT - IN HUMANS
APOPTOSIS INDUCTION
Tripterygium wilfordii (CELASTRACEAE)
121512
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERIFORDIN
14569
PHARMACOLOGY OF EXTRACT - IN VIVOPMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONIDE
1282361
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
WILFORDINE
107908
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
WILFORDINE,1-DEACETYL:
1226604
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-3
423964
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTINEPHRITIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
152439
UV SPECTRUM GIVEN FORX-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLTONIDE
1216709
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-1
596417
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE
631235
PHARMACOLOGY OF EXTRACT - IN VITRO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
693390
IDENTIFICATION IN BY TLCWORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATA REPORTED
Tripterygium wilfordii (CELASTRACEAE)
HYPOLIDE
178163
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOPHENOLIDE,NEO:
181460
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE,16-HYDROXY:
395407
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNODEPRESSIVE ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
ZEYLESTERAL,DEMETHYL:
248399
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION AND IDENTIFICATION OF
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
KAURAN-19-OIC ACID,16-ALPHA: 17-HYDROXY: (-):
674812
PHARMACOLOGY OF EXTRACT - IN VITRO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
248406
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION AND IDENTIFICATION OF
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERIFORDIN
631230
PHARMACOLOGY OF EXTRACT - IN VITRO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
503738
PHARMACOLOGY OF EXTRACT - IN VITRO
TUMOR NECROSING FACTOR INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
961226
PHARMACOLOGY OF EXTRACT - IN VIVO
TOXICITY ASSESSMENT(QUANTITATIVE)
Tripterygium wilfordii (CELASTRACEAE)
269335
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERFERON-GAMMA SECRETION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
WILFORNINE E
534200
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TW-33
1269863
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
DULCITOL
960691
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIASTHMATIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
269372
PHARMACOLOGY OF COMPOUND - IN VITRO
TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
HYPONINE D
89477
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
TRIPTONOTERPENOL
691358
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1282365
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
ALATUSININE
626541
PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBED
ALLOGRAFT REJECTION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
959875
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
ANTINEPHRITIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
284579
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-1-BETA-SYNTHESIS INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOCHLOROLIDE
421267
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
368693
PHARMACOLOGY OF EXTRACT - IN VITRO
CYCLOOXYGENASE INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
1231017
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
TRIPCHLOROLIDE
560940
PHARMACOLOGY OF COMPOUND - IN VITRO
SPASMOLYTIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
SALASPERMIC ACID
533408
PHARMACOLOGY OF EXTRACT - IN VIVO
HEPATOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
631229
PHARMACOLOGY OF EXTRACT - IN VITRO
APOPTOSIS INDUCTION
Tripterygium wilfordii (CELASTRACEAE)
1269930
PHARMACOLOGY OF EXTRACT - IN VITRO
CARDIOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
165221
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
WILFORTRINE,ISO:
251602
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
REGELINDIOL A
1216876
PHARMACOLOGY OF EXTRACT - IN HUMANS
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
560899
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
HYPOLIDE
760313
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
WILFORINE
490541
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTINEPHRITIC EFFECT
Tripterygium wilfordii (CELASTRACEAE)
1227098
ANTIFERTILITYPHARMACOLOGY OF EXTRACT - IN HUMANS
FSH SYNTHESIS STIMULATION
Tripterygium wilfordii (CELASTRACEAE)
958410
PHARMACOLOGY OF EXTRACT - IN HUMANS
TOXIC EFFECT(GENERAL)
Tripterygium wilfordii (CELASTRACEAE)
699634
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIPROLIFERATION ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
138490
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tripterygium wilfordii (CELASTRACEAE)
OLEAN-12-EN-29-OIC ACID,3-BETA-22-ALPHA-DIHYDROXY:
1226610
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPCHLOROLIDE
14573
X-RAY CHRYSTALLOGRAPHIC STUDIESPHARMACOLOGY OF COMPOUND - IN VIVOMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDE
248411
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION AND IDENTIFICATION OF
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
MANOYL OXIDE-18-OIC ACID,13-EPI:
534181
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TW-26
1223473
PHARMACOLOGY OF COMPOUND - IN VIVO
TOXICITY ASSESSMENT(QUANTITATIVE)
Tripterygium wilfordii (CELASTRACEAE)
WILFORINE
429017
PHARMACOLOGY OF EXTRACT - IN VIVO
PROTEIN SYNTHESIS INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
153971
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Tripterygium wilfordii (CELASTRACEAE)
TRIPTETRAOLIDE,ISO:
1014846
PLANT TISSUE CULTURE MARKER CODEIDENTIFICATION IN BY TLCPHARMACOLOGY OF COMPOUND - IN VITRO
DNA SYNTHESIS INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDETRIPTOLIDE
156669
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
OLEANA-11-13(18)-DIEN-3-ONE
525834
REVIEW OF
Tripterygium wilfordii (CELASTRACEAE)
269396
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERLEUKIN-2 FORMATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
CONGORININE E-1
960681
PHARMACOLOGY OF EXTRACT - IN VIVO
ANALGESIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
138491
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
AMYRIN,ALPHA:
960713
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
209435
ISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTETRAOLIDE,NEO:
1216739
PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY
SPERMICIDAL EFFECT
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-5
1216720
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTERYGIUM COMPONENT T-2-3
1269901
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
INSECTICIDE ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
116780
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
URS-12-EN-28-OIC ACID,2-ALPHA-3-ALPHA-24-TRIHYDROXY:
819538
PLANT TISSUE CULTURE MARKER CODEBIOSYNTHESISISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPDIOLIDE
1216836
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)